KR101580821B1 - Development of a New Synthetic Method for Quinazolinones via Aerobic Oxidation in dimethylsulfoxide - Google Patents

Development of a New Synthetic Method for Quinazolinones via Aerobic Oxidation in dimethylsulfoxide Download PDF

Info

Publication number
KR101580821B1
KR101580821B1 KR1020130132156A KR20130132156A KR101580821B1 KR 101580821 B1 KR101580821 B1 KR 101580821B1 KR 1020130132156 A KR1020130132156 A KR 1020130132156A KR 20130132156 A KR20130132156 A KR 20130132156A KR 101580821 B1 KR101580821 B1 KR 101580821B1
Authority
KR
South Korea
Prior art keywords
group
reaction
yield
quinazolinone
hours
Prior art date
Application number
KR1020130132156A
Other languages
Korean (ko)
Other versions
KR20150050914A (en
Inventor
천철홍
Original Assignee
고려대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고려대학교 산학협력단 filed Critical 고려대학교 산학협력단
Priority to KR1020130132156A priority Critical patent/KR101580821B1/en
Publication of KR20150050914A publication Critical patent/KR20150050914A/en
Application granted granted Critical
Publication of KR101580821B1 publication Critical patent/KR101580821B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

본 발명은 금속과 염기가 배제된 디메틸설폭사이드(dimethylsulfoxid, DMSO) 용매하에서 산소원를 산화제로 사용하는 호기성 산화법을 이용하여 퀴나졸리논 유도체를 제조하는 방법에 관한 것으로, 본 발명에 따른 퀴나졸리논 유도체의 제조방법은 팔라듐이나 이리듐 등과 같은 금속촉매를 필요로 하지 않아 잔존하는 금속에 의한 독성문제가 없으며, 강한 산 또는 염기조건, 저온 반응 및 무수조건의 반응과 같은 까다로운 공정을 필요로 하지 않으며, 별도의 정제공정을 필요로 하지 않아 경제적이고, 간단하게 안트라닐아미드 유도체와 알데히드원을 반응시켜 퀴나졸리논 유도체를 도입할 수 있다. The present invention relates to a method for preparing a quinazolinone derivative by using an aerobic oxidation method using an oxygen source as an oxidizing agent in a dimethylsulfoxide (DMSO) solvent in which a metal and a base are excluded, and a method for producing a quinazolinone derivative Does not require a metal catalyst such as palladium or iridium and thus has no toxicity problem due to the remaining metal and does not require a complicated process such as strong acid or base conditions, It is economical and simple to introduce a quinazolinone derivative by reacting an anthranylamide derivative with an aldehyde source.

Description

디메틸설폭사이드 용매하에서 호기성 산화법을 이용한 퀴나졸리논 유도체의 제조방법{Development of a New Synthetic Method for Quinazolinones via Aerobic Oxidation in dimethylsulfoxide}[0001] The present invention relates to a process for preparing a quinazolinone derivative by an aerobic oxidation method in a dimethylsulfoxide solvent,

본 발명은 금속과 염기가 배제된 디메틸설폭사이드(dimethylsulfoxid, DMSO) 용매하에서 산소원를 산화제로 사용하는 호기성 산화법을 이용하여 퀴나졸리논 유도체를 제조하는 방법에 관한 것이다. The present invention relates to a method for preparing a quinazolinone derivative using an aerobic oxidation method using an oxygen source as an oxidizing agent in a dimethylsulfoxide (DMSO) solvent in which a metal and a base are excluded.

퀴나졸리논 및 퀴나졸리논 유도체는 자연계에 존재하는 천연물질 전구체의 하나로서 재료과학에서 의약 화학 전반에 걸쳐 주요한 전구체로 널리 사용되고 있다. 이와 같은 중요성으로 인하여 퀴나졸리논 유도체를 제조하는 방법의 개발에 관하여 많은 연구가 진행되어 왔다. 퀴나졸리논 유도체를 제조하는 전통적인 방법으로는 안트라닐아미드 유도체와 카르복시산 유도체 사이에 아미드 결합을 형성시킨 후, 강산을 이용하여 탈수반응시켜 퀴나졸리논을 형성시킬 수 있다. 그러나 상기와 같은 방법은 강산과 높은 온도에서 반응을 진행하여야 한다는 단점이 있다. 또 다른 방법으로는 안트라닐아미드와 알데히드 사이에 이민을 형성한 후, 강한 산화제를 이용하여 산화고리화 반응을 일으켜 퀴나졸리논을 합성할 수 있다. 그러나 상기와 같은 산화 고리화 반응은 강한 산화제를 사용하여야 함으로 반응 후 많은 부산물이 형성되기 때문에 반응 용액에서 원하는 화합물을 분리하는데에는 많은 시간과 비용이 들며, 수율이 좋지 않다는 문제점이 있다. Quinazolinones and quinazolinone derivatives are one of the natural precursors present in nature and widely used as a major precursor throughout the entire chemical and medical chemistry in material science. Due to this importance, much research has been conducted on the development of a process for preparing quinazolinone derivatives. Conventional methods for preparing quinazolinone derivatives include forming amide bonds between anthranilamide derivatives and carboxylic acid derivatives, followed by dehydration using strong acids to form quinazolinones. However, the above method has a disadvantage that the reaction should be carried out at a high temperature with a strong acid. Alternatively, quinazolinone can be synthesized by forming an imine between anthranilamide and aldehyde, and then causing an oxidative cyclization reaction using a strong oxidizing agent. However, since the oxidative cyclization reaction requires a strong oxidizing agent, many by-products are formed after the reaction. Therefore, it takes a long time and a long time to separate desired compounds from the reaction solution, and the yield is not good.

상기와 같은 문제점을 해결하기 위하여 최근에는 산소를 직접 반응에 이용하는 호기성산화(aerobic oxidation)가 유기화학 분야에서 주목받고 있다. Fu 그룹에서는 구리-할라이드 촉매 및 염기 존재하에서 호기성 산화법을 이용하여 2-할로벤즈아마이드와 아민화합물을 반응시켜 퀴나졸리논을 제조하는 방법을 개시하고 있으며[Organic Letters 2011, 13, No 6, 1274-1277], Hikawa 그룹에서는 팔라듐 촉매와 TPPMS(TPPMS; sodium (diphenylphosphino) benzene-3-sulfonate) 및 물 용매하에서 호기성산화법을 이용하여 안트라닐아미드와 알데히드를 반응시켜 퀴나졸리논을 제조하고 있다[J. Org. Chem. 2012 77 7046-7051]. 한편, Zuou 그룹에서는 이리듐 촉매를 이용하여 퀴나졸리논 전구체를 합성한 후, 퀴나졸리논을 합성하고 있다. 그러나 상기와 같이 지금까지 개발된 대부분의 호기성 산화의 경우, 산소를 옥시단트로 사용하고 있지만, 기질선택성이 제한되어 있으며, 촉매량의 전이 금속이나 당량 이상의 염기를 필요로 하므로 잔존하는 금속에 의한 독성문제 및 부반응 발생에 대한 문제점이 여전히 남아있다.In order to solve the above problems, aerobic oxidation using oxygen for direct reaction has been attracting attention in the field of organic chemistry. Fu group discloses a method for producing a quinazolinone by reacting 2-halobenzamide with an amine compound using an aerobic oxidation method in the presence of a copper-halide catalyst and a base [Organic Letters 2011, 13, No. 6, 1274- 1277], Hikawa et al. Reported that quinazolinone was prepared by reacting anthranilamide with aldehyde using an aerobic oxidation method in the presence of a palladium catalyst and TPPMS (sodium (diphenylphosphino) benzene-3-sulfonate) and water. Org. Chem. 2012 77 7046-7051]. On the other hand, Zuou group synthesizes quinazolinone precursors using iridium catalysts, and then synthesizes quinazolinones. However, in the case of most of the aerobic oxidation methods developed so far, oxygen is used as oxydane, but since the selectivity of the substrate is limited and a catalytic amount of a transition metal or a base equivalent to the equivalent or more is required, And problems of occurrence of side reactions still remain.

본 발명이 해결하고자 하는 과제는 금속과 염기가 배제된 디메틸설폭사이드(dimethylsulfoxid, DMSO) 존재하에 환경에서 호기성 산화법을 이용하여 퀴나졸리논 유도체를 제조하는 방법을 제공하는 것이다. A problem to be solved by the present invention is to provide a method for preparing a quinazolinone derivative using an aerobic oxidation method in the presence of a metal and a base-free dimethylsulfoxide (DMSO).

상기 상술한 과제를 달성하기 위하여, 본 발명은 하기 [화학식 2]로 표시되는 화합물과 알데히드원을 디메틸설폭사이드 용매하에서 80-200 ℃로 반응시킴으로써 하기 [화학식 1]로 표시되는 화합물을 제조하는 것을 특징으로 하는 퀴나졸리논 유도체의 제조방법을 제공한다:In order to achieve the above-mentioned object, the present invention provides a process for producing a compound represented by the following formula (1) by reacting a compound represented by the following formula (2) and an aldehyde source in a dimethylsulfoxide solvent at 80-200 캜 Which process comprises the steps of:

[화학식 1][Chemical Formula 1]

Figure 112013099632120-pat00001
Figure 112013099632120-pat00001

[화학식 2](2)

Figure 112013099632120-pat00002
Figure 112013099632120-pat00002

상기 알데히드원은 하기 [화학식 3]으로 표시되는 알데히드 및 3,4-디히드로피란 중에서 선택되는 어느 하나 이상인 것을 특징으로 하는 퀴나졸리논 유도체의 제조방법.Wherein the aldehyde source is any one or more selected from aldehydes represented by the following Chemical Formula 3 and 3,4-dihydropyran.

[화학식 3] [3,4-디히드로피란][Chemical Formula 3] [3,4-dihydropyran]

Figure 112013099632120-pat00003
Figure 112013099632120-pat00004
Figure 112013099632120-pat00003
Figure 112013099632120-pat00004

상기 [화학식 1] 내지 [화학식 3]에서,In the above Chemical Formulas 1 to 3,

R1, R2 및 R3는 서로 동일하거나 상이하고, 각각 독립적으로 수소, 할로겐, C1-C10의 직쇄상, 분쇄상 또는 고리상의 탄소사슬을 포함하는 알킬기, 페닐기, 페닐프로페닐기, C7-C14의 알킬페닐기, C7-C14의 알콕시페닐기, 니트로페닐기, 메톡시카보닐페닐, 에톡시카보닐페닐, 아미노페닐기, 시아노페닐, 할로페닐기, 디할로페닐, 트리할로페닐, 퍼할로페닐, 나프틸기, 안트라세닐기 및 C4-C12의 헤테로아릴기 중에서 선택될 수 있다. R 1 , R 2 and R 3 are the same or different and are each independently selected from the group consisting of hydrogen, halogen, an alkyl group containing a carbon chain in the form of a straight, branched or cyclic chain selected from the group consisting of C 1 -C 10, phenyl, phenylpropenyl, C 7 -C 14 C7-C14 alkoxyphenyl, nitrophenyl, methoxycarbonylphenyl, ethoxycarbonylphenyl, aminophenyl, cyanophenyl, halophenyl, dihalophenyl, trihalophenyl, perhalophenyl, naphthyl, An anthracenyl group, and a C4-C12 heteroaryl group.

상기 알킬기는 메틸, 에틸, 노말프로필, 이소프로필, 노말부틸, 이소부틸, tert-부틸, 노말헥실, 이소헥실, 시클로헥실, 노말헵틸, 이소헵틸 및 시클로헵틸로 이루어진 군 중에서 선택되고, Wherein said alkyl group is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-hexyl, isohexyl, cyclohexyl, normal heptyl, isoheptyl and cycloheptyl,

상기 알킬페닐기는 메틸페닐, 에틸페닐, 프로필페닐, 디메틸페닐, 디에틸페닐 및 메틸에틸페닐로 이루어진 군 중에서 선택되며, Wherein the alkylphenyl group is selected from the group consisting of methylphenyl, ethylphenyl, propylphenyl, dimethylphenyl, diethylphenyl and methylethylphenyl,

상기 알콕시페닐기는 메톡시페닐 및 에톡시페닐로 이루어진 군중에서 선택되고, Wherein said alkoxyphenyl group is selected from the group consisting of methoxyphenyl and ethoxyphenyl,

상기 헤테로아릴기는 퓨라닐기, 메틸퓨라닐, 에틸퓨라닐, 디메틸퓨라닐, 디에틸퓨라닐, 티오펜일(thiophenyl)기, 메틸티오펜일, 에틸티오펜일, 디메틸티오펜일, 디에틸티오펜일 및 피리디닐기로 이루어진 군 중에서 선택되는 1종 이상일 수 있으나 이에 한정되지는 않는다. Wherein said heteroaryl group is selected from the group consisting of furanyl, methylfuranyl, ethylfuranyl, dimethylfuranyl, diethylfuranyl, thiophenyl, methylthiophenyl, ethylthiophenyl, dimethylthiophenyl, But are not limited to, at least one member selected from the group consisting of a fluorine atom,

본 발명의 일 실시예에 의하면, 상기 반응은 산소 및 공기 중에서 선택되는 1종 이상의 산소원을 산화제로 사용하여 수행될 수 있는데, 상기 산소원으로는 반응시 산소 분자를 공급할 수 있는 것이면 특별히 제한되지 않으며, 오존, 산소플라즈마, 과산화수소 및 산소가 용해된 용매 중에서 선택되는 어느 하나 또는 하나 이상일 수도 있다. According to an embodiment of the present invention, the reaction may be performed using at least one oxygen source selected from oxygen and air as an oxidizing agent. The oxygen source is not particularly limited as long as it can supply oxygen molecules during the reaction And may be any one or more selected from ozone, oxygen plasma, hydrogen peroxide, and a solvent in which oxygen is dissolved.

본 발명의 다른 일 실시예에 의하면, 상기 반응은 1-60시간 동안 반응시킴으로써 수행될 수 있다. According to another embodiment of the present invention, the reaction can be carried out by reacting for 1-60 hours.

상기 반응은 물을 부산물로 생산할 수 있다. The reaction can produce water as a by-product.

본 발명에 따른 퀴나졸리논 유도체를 제조하는 방법은 산소원을 산화제로 사용하여 디메틸설폭사이드의 존재하에서 열만을 제공함으로써 친환경적으로 퀴나졸리논을 제조할 수 있다. 본 발명에 따른 퀴나졸리논 유도체의 제조방법은 팔라듐이나 이리듐 등과 같은 금속촉매를 필요로 하지 않아 잔존하는 금속에 의한 독성문제가 없으며, 강한 산 또는 염기조건, 저온 반응 및 무수조건의 반응과 같은 까다로운 공정을 필요로 하지 않으며, 별도의 정제공정을 필요로 하지 않아 경제적이고, 간단하게 안트라닐아미드 유도체와 알데히드원을 반응시켜 퀴나졸리논 유도체를 도입할 수 있다. The process for preparing the quinazolinone derivative according to the present invention can produce quinazolinone in an environmentally friendly manner by using only an oxygen source in the presence of dimethylsulfoxide as an oxidizing agent. The process for preparing a quinazolinone derivative according to the present invention does not require a metal catalyst such as palladium or iridium and thus has no toxicity problem due to the remaining metal, and can be used in a severe acid or base condition, a low temperature reaction, It is economical and simple that an anthranilamide derivative and an aldehyde source are reacted to introduce a quinazolinone derivative.

도 1은 본 발명의 실시예 1-3의 1H-핵자기공명 스펙트럼(nuclear magnetic resonance spectrum)이다(a: 실시예 1, b: 실시예 2, c: 실시예 3).
도 2는 본 발명의 실시예 4-6의 1H-핵자기공명 스펙트럼(nuclear magnetic resonance spectrum)이다(a: 실시예 4, b: 실시예 5, c: 실시예 6).
도 3은 본 발명의 실시예 7-9의 1H-핵자기공명 스펙트럼(nuclear magnetic resonance spectrum)이다(a: 실시예 7, b: 실시예 8, c: 실시예 9).
도 4은 본 발명의 실시예 10-12의 1H-핵자기공명 스펙트럼(nuclear magnetic resonance spectrum)이다(a: 실시예 10, b: 실시예 11, c: 실시예 12).
도 5는 본 발명의 실시예 13-15의 1H-핵자기공명 스펙트럼(nuclear magnetic resonance spectrum)이다(a: 실시예 13, b: 실시예 14, c: 실시예 15).
도 6은 본 발명의 실시예 16-18의 1H-핵자기공명 스펙트럼(nuclear magnetic resonance spectrum)이다(a: 실시예 16, b: 실시예 17, c: 실시예 18).
도 7은 본 발명의 실시예 22-24의 1H-핵자기공명 스펙트럼(nuclear magnetic resonance spectrum)이다(a: 실시예 22, b: 실시예 23, c: 실시예 24).
도 8은 본 발명의 실시예 26-28의 1H-핵자기공명 스펙트럼(nuclear magnetic resonance spectrum)이다(a: 실시예 26, b: 실시예 27, c: 실시예 28).
도 9는 본 발명의 실시예 30-32의 1H-핵자기공명 스펙트럼(nuclear magnetic resonance spectrum)이다(a: 실시예 30, b: 실시예 31, c: 실시예 32).
도 10은 본 발명의 실시예 33, 34 및 37의 1H-핵자기공명 스펙트럼(nuclear magnetic resonance spectrum)이다(a: 실시예 33, b: 실시예 34, c: 실시예 37).
도 11은 본 발명의 실시예 38의 1H-핵자기공명 스펙트럼(nuclear magnetic resonance spectrum)이다(a: 2-(4-hydroxybutyl)quinazolin-4(3H)-one, b: 8,9-dihydro-6H-pyrido[2,1-b]quinazolin-11(7H)-one.
1 is a 1 H-nuclear magnetic resonance spectrum of Example 1-3 of the present invention (a: Example 1, b: Example 2, c: Example 3).
2 is a 1 H-nuclear magnetic resonance spectrum of Example 4-6 of the present invention (a: Example 4, b: Example 5, c: Example 6).
3 is a 1 H-nuclear magnetic resonance spectrum of Example 7-9 of the present invention (a: Example 7, b: Example 8, c: Example 9).
4 is a 1 H-nuclear magnetic resonance spectrum of Example 10-12 of the present invention (a: Example 10, b: Example 11, c: Example 12).
5 is a 1 H-nuclear magnetic resonance spectrum of Example 13-15 of the present invention (a: Example 13, b: Example 14, c: Example 15).
6 is a 1 H-nuclear magnetic resonance spectrum of Example 16-18 of the present invention (a: Example 16, b: Example 17, c: Example 18).
FIG. 7 is a 1 H-nuclear magnetic resonance spectrum of Example 22-24 of the present invention (a: Example 22, b: Example 23, c: Example 24).
8 is a 1 H-nuclear magnetic resonance spectrum of Example 26-28 of the present invention (a: Example 26, b: Example 27, c: Example 28).
9 is a 1 H-nuclear magnetic resonance spectrum of Example 30-32 of the present invention (a: Example 30, b: Example 31, c: Example 32).
10 is a 1 H-nuclear magnetic resonance spectrum of Examples 33, 34 and 37 of the present invention (a: Example 33, b: Example 34, c: Example 37).
11 is a 1 H-nuclear magnetic resonance spectrum of Example 38 of the present invention (a: 2- (4-hydroxybutyl) quinazolin-4 (3H) -one, b: 8,9-dihydro -6H-pyrido [2,1-b] quinazolin-11 (7H) -one.

이하 본 발명을 더욱 상세하게 설명한다. Hereinafter, the present invention will be described in more detail.

본 발명은 하기 [화학식 2]로 표시되는 화합물과 알데히드원을 디메틸설폭사이드 용매하에서 80-200 ℃로 반응시킴으로써 하기 [화학식 1]로 표시되는 화합물을 제조하는 것을 특징으로 하는 퀴나졸리논 유도체의 제조방법을 제공한다:The present invention relates to a process for producing a quinazolinone derivative, which comprises reacting a compound represented by the following formula (2) and an aldehyde source in a dimethylsulfoxide solvent at 80-200 캜 to produce a compound represented by the following formula The method provides:

[화학식 1][Chemical Formula 1]

Figure 112013099632120-pat00005
Figure 112013099632120-pat00005

[화학식 2](2)

Figure 112013099632120-pat00006
Figure 112013099632120-pat00006

상기 [화학식 1] 또는 [화학식 2]에서, In the above Chemical Formula 1 or Chemical Formula 2,

상기 R1, R2 및 R3는 서로 동일하거나 상이하고, 각각 독립적으로 수소, 할로겐, C1-C10의 직쇄상, 분쇄상 또는 고리상의 탄소사슬을 포함하는 알킬기, 페닐기, 페닐프로페닐기, C7-C14의 알킬페닐기, C7-C14의 알콕시페닐기, 니트로페닐기, 메톡시카보닐페닐, 에톡시카보닐페닐, 아미노페닐기, 시아노페닐, 할로페닐기, 디할로페닐, 트리할로페닐, 퍼할로페닐, 나프틸기, 안트라세닐기 및 C4-C12의 헤테로아릴기 중에서 선택될 수 있다. R 1 , R 2 and R 3 are the same or different and each independently represents an alkyl group containing a carbon chain of hydrogen, halogen, a C 1 -C 10 linear, branched or cyclic group, a phenyl group, a phenylpropenyl group, C14 alkylphenyl, C7-C14 alkoxyphenyl, nitrophenyl, methoxycarbonylphenyl, ethoxycarbonylphenyl, aminophenyl, cyanophenyl, halophenyl, dihalophenyl, trihalophenyl, perhalophenyl, A naphthyl group, an anthracenyl group, and a C4-C12 heteroaryl group.

상기 알킬기는 메틸, 에틸, 노말프로필, 이소프로필, 노말부틸, 이소부틸, tert-부틸, 노말헥실, 이소헥실, 시클로헥실, 노말헵틸, 이소헵틸 및 시클로헵틸로 이루어진 군 중에서 선택되고, Wherein said alkyl group is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-hexyl, isohexyl, cyclohexyl, normal heptyl, isoheptyl and cycloheptyl,

상기 알킬페닐기는 메틸페닐, 에틸페닐, 프로필페닐, 디메틸페닐, 디에틸페닐 및 메틸에틸페닐로 이루어진 군 중에서 선택되며, Wherein the alkylphenyl group is selected from the group consisting of methylphenyl, ethylphenyl, propylphenyl, dimethylphenyl, diethylphenyl and methylethylphenyl,

상기 알콕시페닐기는 메톡시페닐 및 에톡시페닐로 이루어진 군중에서 선택되고, Wherein said alkoxyphenyl group is selected from the group consisting of methoxyphenyl and ethoxyphenyl,

상기 헤테로아릴기는 퓨라닐기, 메틸퓨라닐, 에틸퓨라닐, 디메틸퓨라닐, 디에틸퓨라닐, 티오펜일(thiophenyl)기, 메틸티오펜일, 에틸티오펜일, 디메틸티오펜일, 디에틸티오펜일 및 피리디닐기로 이루어진 군 중에서 선택되는 1종 이상일 수 있으나 이에 한정되지는 않는다. Wherein said heteroaryl group is selected from the group consisting of furanyl, methylfuranyl, ethylfuranyl, dimethylfuranyl, diethylfuranyl, thiophenyl, methylthiophenyl, ethylthiophenyl, dimethylthiophenyl, But are not limited to, at least one member selected from the group consisting of a fluorine atom,

상기 반응은 산소 및 공기 중에서 선택되는 1종 이상의 산소원을 산화제로 사용하여 수행되는 호기성 산화를 특징으로 하는데, 상기 산소원으로는 반응시 산소 분자를 공급할 수 있는 것이면 특별히 제한되지 않으며, 반응물이 공기에 노출될 수 있도록 반응용기를 밀폐시키지 않고 입구를 개방시킨 오픈플라스크 시스템을 사용하여 교반함으로써 산소원을 제공할 수도 있고, 오존, 산소플라즈마, 과산화수소 및 산소가 용해된 용매 중에서 선택되는 어느 하나 또는 하나 이상을 이용할 수도 있다. 다만, 산소를 산화제로 사용하는 경우에는 짧은 시간내에 높은 수율로 퀴나졸리논 유도체를 얻을 수 있어 바람직하며, 상기 오픈플라스크 시스템을 이용하는 경우에는 산업상 이용시 경제적이며, 안전함으로 바람직하다.The reaction is characterized by an aerobic oxidation carried out using at least one oxygen source selected from oxygen and air as an oxidizing agent. The oxygen source is not particularly limited as long as it can supply oxygen molecules during the reaction, An oxygen source may be provided by stirring using an open flask system in which the inlet is opened without closing the reaction vessel so that the reaction vessel may be exposed to the atmosphere, or any one or one selected from ozone, oxygen plasma, hydrogen peroxide, Or more may be used. However, when oxygen is used as an oxidizing agent, a quinazolinone derivative can be obtained in a high yield in a short time. It is preferable that the open flask system is economical and safe in industrial use.

본 발명에 따르면 상기 알데히드원은 알데히드 및 반응시 알데히드로 전환될 수 있는 화합물을 의미하는데, 본 발명에 따른 알데히드원은 하기 [화학식 3]으로 표시되는 알데히드 및 3,4-디히드로피란 중에서 선택되는 어느 하나 이상일 수 있다:According to the present invention, the aldehyde source means a compound capable of being converted to an aldehyde and an aldehyde upon the reaction. The aldehyde source according to the present invention is selected from an aldehyde represented by the following Chemical Formula 3 and 3,4-dihydropyran It can be any one or more:

[화학식 3] [3,4-디히드로피란][Chemical Formula 3] [3,4-dihydropyran]

Figure 112013099632120-pat00007
Figure 112013099632120-pat00008
Figure 112013099632120-pat00007
Figure 112013099632120-pat00008

상기 [화학식 3]에서,In the above formula 3,

R1은 수소, 할로겐, C1-C10의 직쇄상, 분쇄상 또는 고리상의 탄소사슬을 포함하는 알킬기, 페닐기, 페닐프로페닐기, C7-C14의 알킬페닐기, C7-C14의 알콕시페닐기, 니트로페닐기, 메톡시카보닐페닐, 에톡시카보닐페닐, 아미노페닐기, 시아노페닐, 할로페닐기, 디할로페닐, 트리할로페닐, 퍼할로페닐, 나프틸기, 안트라세닐기 및 C4-C12의 헤테로아릴기 중에서 선택될 수 있는데,R 1 represents a hydrogen atom, a halogen atom, an alkyl group containing a linear, branched or cyclic C1-C10 carbon chain, a phenyl group, a phenylpropenyl group, an alkylphenyl group of C7-C14, an alkoxyphenyl group of C7- The heterocyclic group is selected from the group consisting of an alkyl group, an alkoxy group, an alkoxy group, an alkoxy group, an alkoxy group, an alkoxycarbonyl group, an alkoxycarbonyl group, an alkoxycarbonylphenyl group, an ethoxycarbonylphenyl group, an aminophenyl group, a cyanophenyl group, a halophenyl group, dihalophenyl, trihalophenyl, perhalophenyl, However,

상기 알킬기는 메틸, 에틸, 노말프로필, 이소프로필, 노말부틸, 이소부틸, tert-부틸, 노말헥실, 이소헥실, 시클로헥실, 노말헵틸, 이소헵틸 및 시클로헵틸로 이루어진 군 중에서 선택되고, Wherein said alkyl group is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-hexyl, isohexyl, cyclohexyl, normal heptyl, isoheptyl and cycloheptyl,

상기 알킬페닐기는 메틸페닐, 에틸페닐, 프로필페닐, 디메틸페닐, 디에틸페닐 및 메틸에틸페닐로 이루어진 군 중에서 선택되며, Wherein the alkylphenyl group is selected from the group consisting of methylphenyl, ethylphenyl, propylphenyl, dimethylphenyl, diethylphenyl and methylethylphenyl,

상기 알콕시페닐기는 메톡시페닐 및 에톡시페닐로 이루어진 군중에서 선택되고, Wherein said alkoxyphenyl group is selected from the group consisting of methoxyphenyl and ethoxyphenyl,

상기 헤테로아릴기는 퓨라닐기, 메틸퓨라닐, 에틸퓨라닐, 디메틸퓨라닐, 디에틸퓨라닐, 티오펜일(thiophenyl)기, 메틸티오펜일, 에틸티오펜일, 디메틸티오펜일, 디에틸티오펜일 및 피리디닐기로 이루어진 군 중에서 선택되는 1종 이상일 수 있으나 이에 한정되지는 않는다. Wherein said heteroaryl group is selected from the group consisting of furanyl, methylfuranyl, ethylfuranyl, dimethylfuranyl, diethylfuranyl, thiophenyl, methylthiophenyl, ethylthiophenyl, dimethylthiophenyl, But are not limited to, at least one member selected from the group consisting of a fluorine atom,

상기 알데히드원으로서 3,4-디히드로피란을 사용하는 경우에는 본 발명에 따른 퀴나졸리논을 제조하기 위하여 상기 3,4-디히드로피란; 안트라닐아미드 유도체; 산소원; 및 디메틸설폭사이드에 염기를 더 첨가하여 80-200 ℃에서 1-60시간 동안 반응시킴으로써 제조될 수 있는데, 바람직하게는 100 ℃ 이상의 온도인 것이 반응속도가 빠르고 높은 수율로 퀴나졸리논이 생성될 수 있다. 반응온도가 상기 범위 이하이면 호기성 산화가 거의 일어나지 않아 퀴나졸리논이 생성되지 않거나, 생성된 퀴나졸리논의 양이 미미함으로 바람직하지 않으며, 반응온도가 상기 범위 이상이면 반응속도 및 수율이 향상되는 정도가 없거나 미미하여 경제적이지 않으므로 바람직하지 않다. When 3,4-dihydropyran is used as the aldehyde source, the 3,4-dihydropyran is used in order to prepare the quinazolinone according to the present invention. Anthranilamide derivatives; Oxygen source; And dimethylsulfoxide at 80 to 200 ° C for 1 to 60 hours, preferably at a temperature of 100 ° C or more, the reaction rate is fast and quinazolinone is produced at a high yield have. If the reaction temperature is lower than the above range, aerobic oxidation hardly occurs and quinazolinone is not produced or the amount of quinazolinone produced is insignificant. When the reaction temperature is in the above range, the reaction rate and yield are improved It is not desirable because it is not economical because it is not present or small.

상기 알데히드원으로서 3,4-디히드로피란을 사용하는 경우에 사용되는 염기는 3,4-디히드로피란을 알데히드로 전환시켜 줄 수 있는 염기이면 제한은 없으며, 구체적으로 p-톨루엔설포닉산(p-toluenesulfonic acid, TsOH)일 수 있다.The base used when 3,4-dihydropyrane is used as the aldehyde source is not limited as long as it can convert 3,4-dihydropyran to aldehyde. Specifically, p-toluenesulfonic acid (p -toluenesulfonic acid, TsOH).

본 발명에 따르면, 상기 반응은 용매로 디메틸설폭사이드를 사용하는 것이 금속촉매나 염기를 사용하지 않고도, 반응 수율이 높고, 짧은 시간에 퀴나졸리논 산화고리화 반응이 이루어지므로 바람직하나 이에 한정되지는 않는다. 예를 들어, 디메틸포름아미드를 용매로 사용하는 경우에도 반응은 진행되나, 반응시간이 길며, 수율이 낮고, 이민 부산물이 생성되므로 바람직하지 않다. According to the present invention, dimethylsulfoxide is used as a solvent because the reaction yield is high and a quinazolinone oxidative cyclization reaction is performed in a short time without using a metal catalyst or a base, Do not. For example, when dimethylformamide is used as a solvent, the reaction proceeds, but the reaction time is long, the yield is low, and immigration by-products are generated, which is not preferable.

본 발명에 따르면 상기 반응은 용매로 디메틸설폭사이드를 사용하여 수행될 수 있으나, 디메틸설폭사이드에 다른 유기용매를 첨가하여 사용하는 경우에도 퀴나졸리논 산화고리화 반응이 이루어질 수 있다. 다만 후자의 경우 디메틸설폭사이드만을 이용하는 경우에 비하여 퀴나졸리논이 합성되는 시간이 길어질 수 있으나, 생성된 퀴나졸리논에 치환체를 도입시키는데 있어서 별도의 분리과정 없이 치환체를 첨가하여 one-pot 반응으로 진행시킬 수 있어 바람직하게 이용될 수 있다. According to the present invention, the reaction can be carried out using dimethylsulfoxide as a solvent, but even when another organic solvent is added to dimethylsulfoxide, a quinazolinone oxidative cyclization reaction can be performed. However, in the latter case, the time for synthesizing quinazolinone may be longer than in the case of using only dimethylsulfoxide. However, in order to introduce a substituent into the resulting quinazolinone, a substituent is added to the resulting quinazolinone to effect a one-pot reaction And can be preferably used.

예를 들어, 하기 [반응식 1]에 나타낸 바와 같이, 본 발명에 따라 안트라닐아미드 유도체와 알데히드에 용매로 디메틸설폭사이드만을 첨가하여 호기성 산화법을 이용하여 반응시키는 경우에는 반응시간이 짧고 높은 수율로 퀴나졸리논이 생성되며, 안정적으로 유지된다는 장점이 있다. For example, as shown in Reaction Scheme 1 below, when an anthranilamide derivative and an aldehyde are reacted using an aerobic oxidation method by adding only dimethylsulfoxide as a solvent according to the present invention, the reaction time is short, Jollyonone is produced and is stable.

본 발명에 따라 안트라닐아미드 유도체와 알데히드를 넣은 반응용기에 용매로 디메틸설폭사이드에 다른 유기용매를 첨가하고 호기성 산화법을 이용하여 반응시키는 경우에는 반응시간은 디메틸설폭사이드에 비해 길어질 수 있지만 혼합되는 용매에 따라 산업상 경제성 및 안정성을 갖출 수 있다. 본 발명에 따른 퀴나졸리논 제조방법은 부산물로 물이 생성되기 때문에 별도의 정제과정을 필요로 하지 않으며, 상기 반응용기에 치환체를 더 첨가하여 반응시키는 것으로 치환체가 도입된 퀴나졸리논을 제조할 수 있다.When a reaction vessel containing an anthranilamide derivative and an aldehyde according to the present invention is added with another organic solvent to dimethylsulfoxide as a solvent and reacted using an aerobic oxidation method, the reaction time may be longer than that of dimethylsulfoxide, It can be economically and economically stable. The process for preparing quinazolinone according to the present invention does not require a separate purification process because water is produced as a by-product, and a quinazolinone into which the substituent is introduced can be prepared by further adding a substituent to the reaction vessel have.

[반응식 1][Reaction Scheme 1]

Figure 112013099632120-pat00009

Figure 112013099632120-pat00009

본 발명에 따르면, 상기 디메틸설폭사이드(Dimethyl sulfoxide, DMSO)와 함께 사용되는 유기용매로는 디메틸포름아미드(dimethylformamide, DMF), 테트라하이드로퓨란, 다이옥산, 아세토니트릴, 물, 메틸렌클로라이드, 클로로포름 및 톨루엔을 포함하는 군 중에서 선택되는 1종 이상일 수 있으나, 이에 한정되지는 않는다. According to the present invention, the organic solvent used together with dimethyl sulfoxide (DMSO) may include dimethylformamide (DMF), tetrahydrofuran, dioxane, acetonitrile, water, methylene chloride, chloroform, But the present invention is not limited thereto.

상기 디메틸설폭사이드만을 용매로 사용하는 경우는 촉매 또는 염기를 사용하여도 반응이 진행될 수 있으나, 상기 촉매 또는 염기를 사용하는 경우에는 합성수율이 떨어짐으로 본 발명에 따른 바와 같이 촉매를 사용하지 않는 것이 좀더 바람직하다. In the case where only dimethylsulfoxide is used as a solvent, the reaction may proceed even with the use of a catalyst or a base. However, when the catalyst or the base is used, the synthesis yield is lowered. More desirable.

또한, 본 발명에 따르면, 상기 퀴나졸리논 제조방법은 물을 더 포함하는 것이 바람직한데, 수분이 제외된 환경에서는 퀴나졸리논이 생성되지 않고, 이민 중간체가 생성될 수 있으므로 바람직하지 않다. In addition, according to the present invention, it is preferable that the process for producing the quinazolinone further comprises water, but quinazolinone is not produced in an environment in which moisture is excluded, and an imine intermediate may be produced.

본 발명에 따르면 산소원 공급시 오픈플라스크 시스템을 이용하면, 공기 중에 함유된 수증기로부터 수분을 공급할 수 있어 별도의 과정을 통해 물을 첨가하지 않아도 반응이 수행될 수 있다. According to the present invention, when the open source flask system is used to supply the oxygen source, moisture can be supplied from the water vapor contained in the air, so that the reaction can be performed without adding water through a separate process.

상기 반응은 부산물로 물을 생산한다. The reaction produces water as a by-product.

본 발명에 따른 상기 [화학식 1]로 표시되는 화합물은 구체적으로 하기 [화학식 4] 내지 [화학식 38]로 이루어진 군 중에서 선택되는 1종 이상 일 수 있다. The compound represented by the formula (1) according to the present invention may be specifically at least one compound selected from the following formulas (4) to (38).

[화학식 4] [화학식 5] [화학식 6][Chemical Formula 4] < EMI ID =

Figure 112013099632120-pat00010
Figure 112013099632120-pat00011
Figure 112013099632120-pat00012
Figure 112013099632120-pat00010
Figure 112013099632120-pat00011
Figure 112013099632120-pat00012

[화학식 7] [화학식 8] [화학식 9][Chemical Formula 8] < EMI ID =

Figure 112013099632120-pat00013
Figure 112013099632120-pat00014
Figure 112013099632120-pat00015
Figure 112013099632120-pat00013
Figure 112013099632120-pat00014
Figure 112013099632120-pat00015

[화학식 10] [화학식 11] [화학식 12][Chemical Formula 11] [Chemical Formula 12]

Figure 112013099632120-pat00016
Figure 112013099632120-pat00017
Figure 112013099632120-pat00018
Figure 112013099632120-pat00016
Figure 112013099632120-pat00017
Figure 112013099632120-pat00018

[화학식 13] [화학식 14] [화학식 15][Chemical Formula 14] [Chemical Formula 15]

Figure 112013099632120-pat00019
Figure 112013099632120-pat00020
Figure 112013099632120-pat00021
Figure 112013099632120-pat00019
Figure 112013099632120-pat00020
Figure 112013099632120-pat00021

[화학식 16] [화학식 17] [화학식 18][Chemical Formula 18] [Chemical Formula 18]

Figure 112013099632120-pat00022
Figure 112013099632120-pat00023
Figure 112013099632120-pat00024
Figure 112013099632120-pat00022
Figure 112013099632120-pat00023
Figure 112013099632120-pat00024

[화학식 19] [화학식 20] [화학식 21][Chemical Formula 20]

Figure 112013099632120-pat00025
Figure 112013099632120-pat00026
Figure 112013099632120-pat00027
Figure 112013099632120-pat00025
Figure 112013099632120-pat00026
Figure 112013099632120-pat00027

[화학식 22] [화학식 23] [화학식 24][Chemical Formula 22]

Figure 112013099632120-pat00028
Figure 112013099632120-pat00029
Figure 112013099632120-pat00030
Figure 112013099632120-pat00028
Figure 112013099632120-pat00029
Figure 112013099632120-pat00030

[화학식 25] [화학식 26] [화학식 27][Chemical Formula 25]

Figure 112013099632120-pat00031
Figure 112013099632120-pat00032
Figure 112013099632120-pat00033
Figure 112013099632120-pat00031
Figure 112013099632120-pat00032
Figure 112013099632120-pat00033

[화학식 28] [화학식 29] [화학식 30][Chemical Formula 30]

Figure 112013099632120-pat00034
Figure 112013099632120-pat00035
Figure 112013099632120-pat00036
Figure 112013099632120-pat00034
Figure 112013099632120-pat00035
Figure 112013099632120-pat00036

[화학식 31] [화학식 32] [화학식 33][Chemical Formula 32] [Chemical Formula 33]

Figure 112013099632120-pat00037
Figure 112013099632120-pat00038
Figure 112013099632120-pat00039
Figure 112013099632120-pat00037
Figure 112013099632120-pat00038
Figure 112013099632120-pat00039

[화학식 34] [화학식 35] [화학식 36][Chemical Formula 35] [Chemical Formula 35]

Figure 112013099632120-pat00040
Figure 112013099632120-pat00041
Figure 112013099632120-pat00042
Figure 112013099632120-pat00040
Figure 112013099632120-pat00041
Figure 112013099632120-pat00042

[화학식 37] [화학식 38][Chemical Formula 37]

Figure 112013099632120-pat00043
Figure 112013099632120-pat00044

Figure 112013099632120-pat00043
Figure 112013099632120-pat00044

이하 본 발명을 바람직한 실시예를 참고로 하여 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되는 것은 아니다.
Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings. The present invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein.

실시예Example

하기 실시예는 별도로 명시하지 않은 한 모든 반응은 반응물을 공기에 노출시키는 분위기에서 수행되었으며, 얇은막크로마토그래피법을 이용하여 반응 진행 정도를 체크하였다. 본 발명에 따른 실시예에서 제조된 화합물들은 베리안 제미니 300(Varian Gemini 300; 300 MHz), 베리안 제미니 400(Varian Gemini 400; 400 MHz) 또는 브루커 600(Bruker 600; 600 MHz) 이용하여 핵자기공명(Nuclear magnetic resonace; NMR)스펙트럼을 측정하였다.
In the following examples, unless otherwise stated, all reactions were carried out in an atmosphere in which the reactants were exposed to air, and the progress of the reaction was checked using a thin film chromatography method. The compounds prepared in the examples according to the present invention were analyzed using a Varian Gemini 300 (300 MHz), a Varian Gemini 400 (400 MHz) or a Bruker 600 (600 MHz) Nuclear magnetic resonance (NMR) spectra were measured.

실시예Example 1. 2- 1. 2- PhenylquinazolinPhenylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00045
Figure 112013099632120-pat00045

반응용기에 안트라닐아미드 1.0 mmol 및 벤즈알데히드 1.2 mmol을 넣고 디메틸설폭사이드 5 mL에 용해시킨 후 오픈플라스크 시스템으로 100 ℃에서 교반시켰으며, 중간에 박막크로마토그래피법으로 반응 진행 여부를 확인하였다. 안트라닐아미드가 모두 소진되면 반응 종료시키고, 실온으로 냉각시킨 뒤 물 100 mL을 첨가하여 침전을 형성시켰으며 여과하여 침전물을 수득하였다. 상기 침전물을 에탄올에서 재결정하여 목적하는 화합물을 얻었다. 또한, 결정 여액에 남은 목적 화합물을 추가로 수득하기 위하여 헥산:에틸아세테이트=3:1 내지 1:1인 용매를 사용하여 실리카겔 컬럼크로마토 그래피법으로 분리하여 목적하는 화합물을 얻었다. 반응시간 12시간.1.0 mmol of anthranilamide and 1.2 mmol of benzaldehyde were placed in a reaction vessel and dissolved in 5 mL of dimethylsulfoxide. The reaction mixture was stirred at 100 째 C in an open flask system, and the reaction was progressed by thin layer chromatography. When the anthranylamide was exhausted, the reaction was terminated, and after cooling to room temperature, 100 mL of water was added to form a precipitate, which was then filtered to obtain a precipitate. The precipitate was recrystallized in ethanol to obtain the desired compound. Further, in order to further obtain the objective compound remaining in the crystal filtrate, the desired compound was obtained by silica gel column chromatography using a solvent of hexane: ethyl acetate = 3: 1 to 1: 1. Reaction time 12 hours.

A white solid. Yield: 0.200 g (90 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 8.18 (d, J = 7.43 Hz, 3H), 7.88 (t, J = 7.43 Hz, 1H), 7.78 (d, J = 8.22 Hz, 1H), 7.55-7.65 (m, 4H).
A white solid. Yield: 0.200 g (90%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 8.18 (d, J = 7.43 Hz, 3H), 7.88 (t, J = 7.43 Hz, 1H), 7.78 (d, J = 8.22 Hz, 1H) , 7.55-7.65 (m, 4H).

실시예Example 2. 2-(4- 2. 2- (4- MethoxyphenylMethoxyphenyl )) quinazolinquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00046
Figure 112013099632120-pat00046

벤즈알데히드 대신에 4-메톡시벤즈알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 12시간.The objective compound was obtained by the method of Example 1 except that 4-methoxybenzaldehyde was used instead of benzaldehyde. Reaction time 12 hours.

A white solid. Yield: 0.212 g (84 %). H NMR (400 MHz, DMSO-d6, ppm) δ 12.37 (s, 1H), 8.16 (d, J = 8.61 Hz, 2H), 8.10 (d, J = 7.83 Hz, 1H), 7.78 (dd, J = 7.83, 7.04 Hz, 1H), 7.67 (d, J = 8.22 Hz, 1H), 7.45 (dd, J = 7.43, 7.04 Hz, 1H), 7.04 (d, J = 9.00 Hz, 2H), 3.82 (s, 3H).
A white solid. Yield: 0.212 g (84%). H NMR (400 MHz, DMSO- d 6, ppm) δ 12.37 (s, 1H), 8.16 (d, J = 8.61 Hz, 2H), 8.10 (d, J = 7.83 Hz, 1H), 7.78 (dd, J = 7.83, 7.04 Hz, 1H) , 7.67 (d, J = 8.22 Hz, 1H), 7.45 (dd, J = 7.43, 7.04 Hz, 1H), 7.04 (d, J = 9.00 Hz, 2H), 3.82 (s , 3H).

실시예Example 3.2-(4- 3.2- (4- MethylphenylMethylphenyl )) quinazolinquinazoline -4(3H)--4 (3H) - one 의one's 제조 Produce

Figure 112013099632120-pat00047
Figure 112013099632120-pat00047

벤즈알데히드 대신에 4-메틸벤즈알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 12시간.Methylbenzaldehyde was used in place of benzaldehyde, the target compound was obtained. Reaction time 12 hours.

white solid. Yield: 0.210 g (89 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 2.43 (s, 1H), 8.13 (d, J = 7.83 Hz, 1H), 8.07 (d, J = 7.43 Hz, 2H), 7.81 (t, J = 7.43 Hz, 1H), 7.71 (d, J = 7.83 Hz, 1H), 7.49 (t, J = 7.43 Hz, 1H), 7.34 (d, J = 7.83 Hz, 2H), 2.37 (s, 3H).
white solid. Yield: 0.210 g (89%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 2.43 (s, 1H), 8.13 (d, J = 7.83 Hz, 1H), 8.07 (d, J = 7.43 Hz, 2H), 7.81 (t, J = 7.43 Hz, 1H), 7.71 (d, J = 7.83 Hz, 1H), 7.49 (t, J = 7.43 Hz, 1H), 7.34 (d, J = 7.83 Hz, 2H), 2.37 (s, 3H) .

실시예Example 4. 2-(4- 4. 2- (4- ChlorophenylChlorophenyl )) quinazolinquinazoline -4(3H)--4 (3H) - one 의one's 제조 Produce

Figure 112013099632120-pat00048
Figure 112013099632120-pat00048

벤즈알데히드 대신에 4-클로로벤즈알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 18시간.The objective compound was obtained by the method of Example 1 except that 4-chlorobenzaldehyde was used instead of benzaldehyde. Reaction time 18 hours.

A white solid. Yield: 0.226 g (88 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 12.60 (s, 1H), 8.13-8.18 (m, 3H), 7.82 (dd, J = 7.43, 7.04 Hz, 1H), 7.71 (d, J = 8.22 Hz, 1H), 7.60 (d, J = 8.61 Hz, 2H), 7.50 (dd, J = 7.43, 7.04 Hz, 1H).
A white solid. Yield: 0.226 g (88%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 12.60 (s, 1H), 8.13-8.18 (m, 3H), 7.82 (dd, J = 7.43, 7.04 Hz, 1H), 7.71 (d, J = 8.22 Hz, 1 H), 7.60 (d, J = 8.61 Hz, 2H), 7.50 (dd, J = 7.43, 7.04 Hz, 1H).

실시예Example 5. 2-(4- 5. 2- (4- MethoxycarbonylphenylMethoxycarbonylphenyl )) quinazolinquinazoline -4(3H)--4 (3H) - one 의one's 제조 Produce

Figure 112013099632120-pat00049
Figure 112013099632120-pat00049

벤즈알데히드 대신에 4-메톡시카보닐벤즈알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 12시간.The objective compound was obtained by the method of Example 1 except that 4-methoxycarbonylbenzaldehyde was used instead of benzaldehyde. Reaction time 12 hours.

A white solid. Yield: 0.276 g (98 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 12.69 (s, 1H), 8.27 (d, J = 8.22 Hz, 2H), 8.14 (d, J = 7.83 Hz, 1H), 8.07 (d, J = 8.22 Hz, 2H), 7.83 (dd, J = 7.43, 7.04 Hz, 1H), 7.74 (d, J = 8.22 Hz, 1H), 7.53 (dd, J = 7.43, 7.04 Hz, 1H), 3.87 (s, 3H). 13C NMR (150 MHz, DMSO-d6, ppm) δ 166.21, 162.50, 152.02, 149.00, 137.49, 134.94, 132.53, 129.64, 128.57, 128.01, 127.32, 126.35, 121.77, 52.66. HRMS (EI) calcd for C16H12N2O3 (M)+ .
A white solid. Yield: 0.276 g (98%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 12.69 (s, 1H), 8.27 (d, J = 8.22 Hz, 2H), 8.14 (d, J = 7.83 Hz, 1H), 8.07 (d, J = 8.22 Hz, 2H), 7.83 (dd, J = 7.43, 7.04 Hz, 1H), 7.74 (d, J = 8.22 Hz, 1H), 7.53 (dd, J = 7.43, 7.04 Hz, 1H), 3.87 ( s, 3H). 13 C NMR (150 MHz, DMSO -d 6, ppm) δ 166.21, 162.50, 152.02, 149.00, 137.49, 134.94, 132.53, 129.64, 128.57, 128.01, 127.32, 126.35, 121.77, 52.66. HRMS (EI) calcd for C 16 H 12 N 2 O 3 (M) +.

실시예Example 6. 2-(4- 6. 2- (4- CyanophenylCyanophenyl )) quinazolinquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00050
Figure 112013099632120-pat00050

벤즈알데히드 대신에 4-시아노벤즈알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 30시간.The objective compound was obtained by the method of Example 1 except that 4-cyanobenzaldehyde was used instead of benzaldehyde. Reaction time 30 hours.

A white solid. Yield: 0.235 g (95 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 12.74 (s, 1H), 7.32 (d, J = 7.04 Hz, 2H), 8.16 (d, J = 7.83 Hz, 1H), 8.03 (d, J = 6.65 Hz, 2H), 7.86 (t, J = 7.43 Hz, 1H), 7.77 (d, J = 8.22 Hz, 1H), 7.56 (dd, J = 7.43, 7.04 Hz, 1H).
A white solid. Yield: 0.235 g (95%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 12.74 (s, 1H), 7.32 (d, J = 7.04 Hz, 2H), 8.16 (d, J = 7.83 Hz, 1H), 8.03 (d, J = 6.65 Hz, 2H), 7.86 (t, J = 7.43 Hz, 1H), 7.77 (d, J = 8.22 Hz, 1H), 7.56 (dd, J = 7.43, 7.04 Hz, 1H).

실시예Example 7. 2-( 7. 2- ( PerfluorophenylPerfluorophenyl )) quinazolinquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00051
Figure 112013099632120-pat00051

벤즈알데히드 대신에 퍼플루오로벤즈알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 30시간.The objective compound was obtained by the method of Example 1 except that perfluorobenzaldehyde was used instead of benzaldehyde. Reaction time 30 hours.

A white solid. Yield: 0.238 g (76 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 13.05 (s, 1H), 8.21 (d, J = 7.83 Hz, 1H), 7.91 (dd, J = 7.83, 7.43 Hz, 1H), 7.77 (d, J = 8.22 Hz, 1H), 7.66 (t, J = 7.43 Hz, 1H).
A white solid. Yield: 0.238 g (76%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 13.05 (s, 1H), 8.21 (d, J = 7.83 Hz, 1H), 7.91 (dd, J = 7.83, 7.43 Hz, 1H), 7.77 ( d, J = 8.22 Hz, 1H), 7.66 (t, J = 7.43 Hz, 1H).

실시예Example 8. 2-(2- 8. 2- (2- MethylphenylMethylphenyl )) quinazolinquinazoline -4(3H)--4 (3H) - one 의one's 제조 Produce

Figure 112013099632120-pat00052
Figure 112013099632120-pat00052

벤즈알데히드 대신에 2-메틸벤즈알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 17시간.2-methylbenzaldehyde was used in place of benzaldehyde, to obtain the target compound. Reaction time 17 hours.

A white solid. Yield: 0.201 g (85 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 12.47 (s, 1H), 8.18(d, J = 7.83 Hz, 1H), 7.85 (dd, J = 7.43, 7.04 Hz, 1H), 7.70 (d, J = 8.22 Hz, 1H), 7.51-7.57 (m, 2H), 7.45 (dd, J = 7.43, 7.04 Hz, 1H), 7.32-7.37 (m, 2H), 2.40 (s, 3H).
A white solid. Yield: 0.201 g (85%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 12.47 (s, 1H), 8.18 (d, J = 7.83 Hz, 1H), 7.85 (dd, J = 7.43, 7.04 Hz, 1H), 7.70 ( (d, J = 8.22 Hz, 1H), 7.51-7.57 (m, 2H), 7.45 (dd, J = 7.43, 7.04 Hz, 1H), 7.32-7.37 (m, 2H), 2.40 (s,

실시예Example 9. 2-(2- 9. 2- (2- ChlorophenylChlorophenyl )) quinazolinquinazoline -4(3H)--4 (3H) - one 의one's 제조 Produce

Figure 112013099632120-pat00053
Figure 112013099632120-pat00053

벤즈알데히드 대신에 2-클로로벤즈알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 17시간.2-chlorobenzaldehyde was used in place of benzaldehyde, to obtain the desired compound. Reaction time 17 hours.

A white solid. Yield: 0.221 g (86 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 12.67 (s, 1H), 8.19 (d, J = 7.83 Hz, 1H), 7.87 (dd, J = 7.83, 7.43 Hz, 1H), 7.64-7.74 (m, 4H) 7.59 (dd, J = 7.43, 7.04 Hz, 2H), 7.51 (dd, J = 7.43, 7.04 Hz, 1H).
A white solid. Yield: 0.221 g (86%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 12.67 (s, 1H), 8.19 (d, J = 7.83 Hz, 1H), 7.87 (dd, J = 7.83, 7.43 Hz, 1H), 7.64- 7.74 (m, 4 H) 7.59 (dd, J = 7.43, 7.04 Hz, 2H), 7.51 (dd, J = 7.43, 7.04 Hz, 1H).

실시예Example 10. 2-( 10. 2- ( NaphthalenNaphthalen -1--One- ylyl )) quinazolinquinazoline -4(3H)--4 (3H) - one 의one's 제조 Produce

Figure 112013099632120-pat00054
Figure 112013099632120-pat00054

벤즈알데히드 대신에 1-나프트알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 36시간.The target compound was obtained by the method of Example 1 except that 1-naphthaldehyde was used instead of benzaldehyde. Reaction time 36 hours.

A light yellow solid. Yield: 0.216 g (79 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 12.65 (s, 1H), 8.21 (d, J = 7.83 Hz, 1H), 8.15 (d, J = 7.83 Hz, 1H), 8.11 (d, J = 8.22 Hz, 1H), 8.04 (d, J = 8.22 Hz, 1H), 7.86 (dd, J = 7.83, 7.43 Hz, 1H), 7.77 (d, J = 7.04 Hz, 1H), 7.72 (d, J = 7.83 Hz, 1H), 7.55 7.65 (m, 4H).
A light yellow solid. Yield: 0.216 g (79%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 12.65 (s, 1H), 8.21 (d, J = 7.83 Hz, 1H), 8.15 (d, J = 7.83 Hz, 1H), 8.11 (d, J = 8.22 Hz, 1H), 8.04 (d, J = 8.22 Hz, 1H), 7.86 (dd, J = 7.83, 7.43 Hz, 1H), 7.77 (d, J = 7.04 Hz, 1H), 7.72 (d, J = 7.83 Hz, 1H), 7.55 7.65 (m, 4H).

실시예Example 11. 2-(2- 11. 2- (2- NaphthalenNaphthalen -1--One- ylyl )) quinazolinquinazoline -4(3H)--4 (3H) - one 의one's 제조 Produce

Figure 112013099632120-pat00055
Figure 112013099632120-pat00055

벤즈알데히드 대신에 2-나프트알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 18시간.The desired compound was obtained by the method of Example 1 except that 2-naphthaldehyde was used instead of benzaldehyde. Reaction time 18 hours.

A light yellow solid. Yield: 0.224 g (82 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 12.65 (s, 1H), 8.79 (s, 1H), 8.27 (d, J = 8.61 Hz, 1H), 8.15 (d, J = 7.83 Hz, 1H), 7.98-8.06 (m, 3H), 7.84 (t, J = 7.43 Hz, 1H), 7.77 (d, J = 8.22 Hz, 1H), 7.58-7.64 (m, 2H), 7.51 (t, J = 7.43 Hz, 1H).
A light yellow solid. Yield: 0.224 g (82%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 12.65 (s, 1H), 8.79 (s, 1H), 8.27 (d, J = 8.61 Hz, 1H), 8.15 (d, J = 7.83 Hz, 1H), 7.98-8.06 (m, 3H ), 7.84 (t, J = 7.43 Hz, 1H), 7.77 (d, J = 8.22 Hz, 1H), 7.58-7.64 (m, 2H), 7.51 (t, J = 7.43 Hz, 1 H).

실시예Example 12. 2-( 12. 2- ( FuranFuran -2--2- ylyl )) quinazolinquinazoline -4(3H)--4 (3H) - one 의one's 제조 Produce

Figure 112013099632120-pat00056
Figure 112013099632120-pat00056

벤즈알데히드 대신에 퓨란-2-카브알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 18시간.2-carbaldehyde was used in place of benzaldehyde, the desired compound was obtained. Reaction time 18 hours.

A white solid. Yield: 0.201 g (95 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 12.49 (s, 1H), 8.09 (d, J = 7.83 Hz, 1H), 7.97 (s, 1H), 7.78 (t, J = 7.43 Hz, 1H), 7.66 (d, J = 8.22 Hz, 1H), 7.60 (s, 1H), 7.46 (dd, J = 7.43, 7.04 Hz, 1H), 6.72 (s, 1H).
A white solid. Yield: 0.201 g (95%). 1 H NMR (400 MHz, DMSO-d 6 , ppm) δ 12.49 (s, 1H), 8.09 (d, J = 7.83 Hz, 1H), 7.97 (s, 1H), 7.78 (t, J = 7.43 Hz, 1H), 7.66 (d, J = 8.22 Hz , 1H), 7.60 (s, 1H), 7.46 (dd, J = 7.43, 7.04 Hz, 1H), 6.72 (s, 1H).

실시예Example 13. 2-( 13. 2- ( ThiophenThiophen -2--2- ylyl )) quinazolinquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00057
Figure 112013099632120-pat00057

벤즈알데히드 대신에 티오펜-2-카브알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 36시간.The objective compound was obtained by the method of Example 1 except that thiophene-2-carbaldehyde was used instead of benzaldehyde. Reaction time 36 hours.

A white solid. Yield: 0.213 g (93 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 12.64 (s, 1H), 8.20 (d, J = 3.13 Hz, 1H), 8.09 (d, J = 7.04 Hz 1H), 7.84 (d, J = 4.70 Hz, 1H), 7.78 (t, J = 7.04 Hz, 1H), 7.62 (d, J = 7.83 Hz, 1H), 7.46 (t, J = 7.43 Hz, 1H), 7.21 (t, J = 3.91 Hz, 1H).
A white solid. Yield: 0.213 g (93%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 12.64 (s, 1H), 8.20 (d, J = 3.13 Hz, 1H), 8.09 (d, J = 7.04 Hz 1H), 7.84 (d, J = 4.70 Hz, 1H), 7.78 (t, J = 7.04 Hz , 7.62 (d, J = 7.83 Hz, 1H), 7.46 (t, J = 7.43 Hz, 1H), 7.21 (t, J = 3.91 Hz, 1H).

실시예Example 14. 2-( 14. 2- ( PyridinPyridine -2--2- ylyl )) quinazolinquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00058
Figure 112013099632120-pat00058

벤즈알데히드 대신에 피콜린알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 36시간.The objective compound was obtained by the method of Example 1 except that picoline aldehyde was used instead of benzaldehyde. Reaction time 36 hours.

A white solid. Yield: 0.214 g (96 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 11.84 (s, 1H), 8.73 (d, J = 3.13 Hz, 1H), 8.43 (d, J = 7.83 Hz 1H), 8.16 (d, J = 7.83 Hz, 1H), 8.05 (t, J = 7.43 Hz, 1H), 7.85 (t, J = 7.43 Hz, 1H), 7.78 (d, J = 7.83 Hz, 1H), 7.64 (dd, J = 5.87, 5.43 Hz, 1H), 7.55 (t, J = 7.43 Hz, 1H).
A white solid. Yield: 0.214 g (96%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 11.84 (s, 1H), 8.73 (d, J = 3.13 Hz, 1H), 8.43 (d, J = 7.83 Hz 1H), 8.16 (d, J = 7.83 Hz, 1H), 8.05 (t, J = 7.43 Hz , 1H), 7.85 (t, J = 7.43 Hz, 1H), 7.78 (d, J = 7.83 Hz, 1H), 7.64 (dd, J = 5.87, 5.43 Hz, 1H), 7.55 (t, J = 7.43 Hz , 1H).

실시예Example 15. (E)-2-( 15. (E) -2- ( StyrylStyryl )) quinazolinquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00059
Figure 112013099632120-pat00059

벤즈알데히드 대신에 (E)-3-(피리딘-2-일)아크릴알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 12시간.(E) -3- (pyridin-2-yl) acrylaldehyde was used in place of benzaldehyde, the objective compound was obtained. Reaction time 12 hours.

A yellow solid. Yield: 0.177 g (71 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 12.37 (s, 1H), 8.13 (d, J = 7.43 Hz, 1H), 7.98 (d, J = 16.43 Hz, 1H), 7.82 (t, J = 7.04 Hz, 1H), 7.69 (dd, J = 7.43, 6.65 Hz, 2H), 7.51-4.73 (m, 4H ), 7.03 (d, J = 16.04 Hz, 1H).
A yellow solid. Yield: 0.177 g (71%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 12.37 (s, 1H), 8.13 (d, J = 7.43 Hz, 1H), 7.98 (d, J = 16.43 Hz, 1H), 7.82 (t, J = 7.04 Hz, 1H), 7.69 (dd, J = 7.43, 6.65 Hz, 2H), 7.51-4.73 (m, 4H), 7.03 (d, J = 16.04 Hz, 1H).

실시예Example 16. 2-( 16. 2- ( terttert -- ButylButyl )) quinazolinquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00060
Figure 112013099632120-pat00060

벤즈알데히드 대신에 피발알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 36시간.The objective compound was obtained by the method of Example 1 except that pivalic aldehyde was used instead of benzaldehyde. Reaction time 36 hours.

A white solid. Yield: 0.085 g (42 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 11.86 (s, 1H), 8.07 (d, J = 7.83 Hz, 1H), 7.76 (dd, J = 8.22, 7.04 Hz 1H), 7.60 (d, J = 7.83 Hz, 1H), 7.46 (t, J = 7.43 Hz, 1H), 1.33 (s, 9H).
A white solid. Yield: 0.085 g (42%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 11.86 (s, 1H), 8.07 (d, J = 7.83 Hz, 1H), 7.76 (dd, J = 8.22, 7.04 Hz 1H), 7.60 (d , J = 7.83 Hz, 1H), 7.46 (t, J = 7.43 Hz, 1H), 1.33 (s, 9H).

실시예Example 17. 2- 17. 2- CyclohexylquinazolinCyclohexylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00061
Figure 112013099632120-pat00061

벤즈알데히드 대신에 시클로섹산카브알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 18시간.The objective compound was obtained by the method of Example 1 except that cyclohexanecarbaldehyde was used instead of benzaldehyde. Reaction time 18 hours.

A white solid. Yield: 0.221 g (97 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 12.07 (s, 1H), 8.03 (d, J = 7.43 Hz, 1H), 7.73 (t, J = 7.04 Hz 1H), 7.56 (d, J = 8.22 Hz, 1H), 7.41 (dd, J = 7.43, 7.04 Hz, 1H), 2.53 (m, 1H ), 1.87 (m, 2H), 1.76 (m, 2H), 1.65 (m, 1H), 1.55(m, 2H), 1.25(m, 3H).
A white solid. Yield: 0.221 g (97%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 12.07 (s, 1H), 8.03 (d, J = 7.43 Hz, 1H), 7.73 (t, J = 7.04 Hz 1H), 7.56 (d, J = 8.22 Hz, 1H), 7.41 (dd, J = 7.43, 2H), 1.65 (m, 2H), 1.65 (m, 2H), 1.65 (m, 2H).

실시예Example 18. 2- 18. 2- HexylquinazolinHexylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00062
Figure 112013099632120-pat00062

벤즈알데히드 대신에 헵타날을 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 36시간.The objective compound was obtained by the method of Example 1 except that heptanal was used instead of benzaldehyde. Reaction time 36 hours.

A white solid. Yield: 0.211 g (92 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 12.18 (s, 1H), 8.09 (d, J = 7.83 Hz, 1H), 7.77 (t, J = 7.04 Hz 1H), 7.60 (d, J = 8.22 Hz, 1H), 7.46 (dd, J = 7.83, 7.04 Hz, 1H), 2.60 (m, 2H ), 1.72 (m, 2H), 1.29 (m, 6H), 0.86 (m, 3H).
A white solid. Yield: 0.211 g (92%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ J = 7.83 Hz, 1H), 7.77 (t, J = 7.04 Hz 1H), 7.60 (d, J = 8.22 Hz, 1H), 7.46 (dd, J = 7.04 Hz, 1 H), 2.60 (m, 2H), 1.72 (m, 2H), 1.29 (m, 6H), 0.86 (m, 3H).

실시예Example 19.  19. QuinazolinQuinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00063
Figure 112013099632120-pat00063

벤즈알데히드 대신에 포름알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 12시간.The objective compound was obtained by the method of Example 1 except that formaldehyde was used instead of benzaldehyde. Reaction time 12 hours.

A white solid. Yield: 0.098 g (67 %). 1H NMR (400 MHz, DMSO-d6, ppm) δ 12.37 (s, 1H), 8.13 (d, J = 7.43 Hz, 1H), 7.98 (d, J = 16.43 Hz, 1H), 7.82 (t, J = 7.04 Hz, 1H), 7.69 (dd, J = 7.43, 6.65 Hz, 2H), 7.51-4.73 (m, 4H ), 7.03 (d, J = 16.04 Hz, 1H).
A white solid. Yield: 0.098 g (67%). 1 H NMR (400 MHz, DMSO -d 6, ppm) δ 12.37 (s, 1H), 8.13 (d, J = 7.43 Hz, 1H), 7.98 (d, J = 16.43 Hz, 1H), 7.82 (t, J = 7.04 Hz, 1H), 7.69 (dd, J = 7.43, 6.65 Hz, 2H), 7.51-4.73 (m, 4H), 7.03 (d, J = 16.04 Hz, 1H).

실시예Example 20. 2-(4- 20. 2- (4- nitrophenylnitrophenyl )) quinazolinquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00064
Figure 112013099632120-pat00064

벤즈알데히드 대신에 4-니트로벤즈알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 12시간.The objective compound was obtained by the method of Example 1 except that 4-nitrobenzaldehyde was used instead of benzaldehyde. Reaction time 12 hours.

white solid. Yield: 95 %
white solid. Yield: 95%

실시예Example 21. 2-(2- 21. 2- (2- nitrophenylnitrophenyl )) quinazolinquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00065
Figure 112013099632120-pat00065

벤즈알데히드 대신에 2-니트로벤즈알데히드를 사용한 것을 제외하고는 실시예 1의 방법으로 목적하는 화합물을 얻었다. 반응시간 15시간.2-nitrobenzaldehyde was used in place of benzaldehyde to obtain the target compound. Reaction time 15 hours.

white solid. Yield: 97 %.
white solid. Yield: 97%.

실시예Example 22. 2,3- 22. 2,3- DiphenylquinazolinDiphenylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00066
Figure 112013099632120-pat00066

반응용기에 N-페닐-안트라닐아미드 1.0 mmol 및 벤즈알데히드 1.2 mmol을 넣고 디메틸설폭사이드 5 mL에 용해시킨 후 오픈플라스크 시스템으로 120 ℃에서 교반시켰으며, 중간에 박막크로마토그래피법으로 반응 진행 여부를 확인하였다. 안트라닐아미드가 모두 소진되면 반응 종료시키고, 실온으로 냉각시킨 뒤 물 및 메틸렌 클로라이드를 이용하여 추출하였다. 유기층을 분리하여 건조제(마그네슘설페이트)로 물을 제거한 후 농축시키고, 상기 농축물을 헥산:에틸아세테이트=5:1인 용매를 사용하여 실리카겔 컬럼크로마토 그래피법으로 분리하여 목적하는 화합물을 얻었다. 반응시간 48시간.1.0 mmol of N-phenyl-anthranilamide and 1.2 mmol of benzaldehyde were placed in a reaction vessel and dissolved in 5 mL of dimethylsulfoxide. The reaction mixture was stirred at 120 ° C. in an open flask system. Respectively. When the anthranylamide was exhausted, the reaction was terminated, cooled to room temperature and extracted with water and methylene chloride. The organic layer was separated, water was removed with a desiccant (magnesium sulfate), and the concentrate was concentrated. The concentrate was separated by silica gel column chromatography using a solvent of hexane: ethyl acetate = 5: 1 to obtain the desired compound. Reaction time 48 hours.

A white solid. Yield: 0.240 g (80 %). 1H NMR (400 MHz, CDCl3, ppm) δ 8.37 (d, J = 7.97 Hz, 1H), 7.83 (m, 2H), 7.58-7.52 (m, 1H), 7.33-7.15 (m, 10H).
A white solid. Yield: 0.240 g (80%). 1 H NMR (400 MHz, CDCl 3, ppm) δ 8.37 (d, J = 7.97 Hz, 1H), 7.83 (m, 2H), 7.58-7.52 (m, 1H), 7.33-7.15 (m, 10H).

실시예Example 23. 2-(4- 23. 2- (4- MethoxyphenylMethoxyphenyl )-3-) -3- phenylquinazolinphenylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00067
Figure 112013099632120-pat00067

벤즈알데히드 대신에 4-메톡시벤즈알데히드를 사용한 것을 제외하고는 실시예 22의 방법으로 목적하는 화합물을 얻었다. 반응시간 48시간.The objective compound was obtained by the method of Example 22 except that 4-methoxybenzaldehyde was used instead of benzaldehyde. Reaction time 48 hours.

A white solid. Yield: 0.254 g (77 %). 1H NMR (400 MHz, CDCl3, ppm) δ 8.34 (d, J = 7.83 Hz, 1H), 7.81-7.80 (m, 2H), 7.52 (m, 2H), 7.36-7.26 (m, 4H), 7.16 (d, J = 7.04 Hz, 2H), 6.72 (d, J = 8.61 Hz, 2H), 3.75 (s, 3H).
A white solid. Yield: 0.254 g (77%). 1 H NMR (400 MHz, CDCl 3, ppm) δ 8.34 (d, J = 7.83 Hz, 1H), 7.81-7.80 (m, 2H), 7.52 (m, 2H), 7.36-7.26 (m, 4H), 7.16 (d, J = 7.04 Hz, 2H), 6.72 (d, J = 8.61 Hz, 2H), 3.75 (s, 3H).

실시예Example 24. 2-(4- 24. 2- (4- MethyphenylMethyphenyl )-3-) -3- phenylquinazolinphenylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00068
Figure 112013099632120-pat00068

벤즈알데히드 대신에 4-메틸벤즈알데히드를 사용한 것을 제외하고는 실시예 22의 방법으로 목적하는 화합물을 얻었다. 반응시간 48시간.The objective compound was obtained by the method of Example 22 except that 4-methylbenzaldehyde was used instead of benzaldehyde. Reaction time 48 hours.

A white solid. Yield: 0.226 g (72 %). 1H NMR (400 MHz, CDCl3, ppm) δ 8.34 (d, J = 7.97 Hz, 1H), 7.82 (m, 2H), 7.55-7.50 (m, 1H), 7.33-7.28 (m, 3H), 7.24-7.21 (m, 2H), 7.17-7.15 (m, 2H), 7.02-6.99 (m, 2H), 2.26 (s, 3H).
A white solid. Yield: 0.226 g (72%). 1 H NMR (400 MHz, CDCl 3, ppm) δ 8.34 (d, J = 7.97 Hz, 1H), 7.82 (m, 2H), 7.55-7.50 (m, 1H), 7.33-7.28 (m, 3H), 7.24-7.21 (m, 2H), 7.17-7.15 (m, 2H), 7.02-6.99 (m, 2H), 2.26 (s, 3H).

실시예Example 25. 2-(4- 25. 2- (4- ChlorophenylChlorophenyl )-3-) -3- phenylquinazolinphenylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00069
Figure 112013099632120-pat00069

벤즈알데히드 대신에 4-클로로벤즈알데히드를 사용한 것을 제외하고는 실시예 22의 방법으로 목적하는 화합물을 얻었다. 반응시간 48시간.The objective compound was obtained by the method of Example 22 except that 4-chlorobenzaldehyde was used instead of benzaldehyde. Reaction time 48 hours.

A white solid. Yield: 0.240 g (72 %).
A white solid. Yield: 0.240 g (72%).

실시예Example 26. 2-(4- 26. 2- (4- MethoxycarbonylphenylMethoxycarbonylphenyl )-3-) -3- phenylquinazolinphenylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00070
Figure 112013099632120-pat00070

벤즈알데히드 대신에 4-메톡시카보닐벤즈알데히드를 사용한 것을 제외하고는 실시예 22의 방법으로 목적하는 화합물을 얻었다. 반응시간 48시간.The objective compound was obtained by the method of Example 22 except that 4-methoxycarbonylbenzaldehyde was used instead of benzaldehyde. Reaction time 48 hours.

A white solid. Yield: 0.301 g (84 %). 1H NMR (400 MHz, CDCl3, ppm) δ 8.35 (d, J = 7.83 Hz, 1H), 7.87 (d, J = 8.22 Hz, 2H), 7.82-7.81 (m, 2H), 7.57-7.53 (m, 1H), 7.41 (d, J = 8.22 Hz, 2H), 7.32-7.26 (m, 3H), 7.13 (d, J = 7.04 Hz, 2H), 3.87 (s, 3H).
A white solid. Yield: 0.301 g (84%). 1 H NMR (400 MHz, CDCl 3, ppm) δ 8.35 (d, J = 7.83 Hz, 1H), 7.87 (d, J = 8.22 Hz, 2H), 7.82-7.81 (m, 2H), 7.57-7.53 ( m, 1H), 7.41 (d , J = 8.22 Hz, 2H), 7.32-7.26 (m, 3H), 7.13 (d, J = 7.04 Hz, 2H), 3.87 (s, 3H).

실시예Example 27. 2-(2- 27. 2- (2- MethyphenylMethyphenyl )-3-) -3- phenylquinazolinphenylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00071
Figure 112013099632120-pat00071

벤즈알데히드 대신에 2-메틸벤즈알데히드를 사용한 것을 제외하고는 실시예 22의 방법으로 목적하는 화합물을 얻었다. 반응시간 48시간.Methylbenzaldehyde was used in place of benzaldehyde, the desired compound was obtained. Reaction time 48 hours.

A white solid. Yield: 0.225 g (72 %). 1H NMR (400 MHz, CDCl3, ppm) δ 8.36 (d, J = 8.22 Hz, 1H), 7.81-7.80 (m, 2H), 7.55-7.51 (m, 1H), 7.27-7.18 (m, 3H), 7.12-6.99 (m, 6H), 2.28 (s, 3H).
A white solid. Yield: 0.225 g (72%). 1 H NMR (400 MHz, CDCl 3, ppm) δ 8.36 (d, J = 8.22 Hz, 1H), 7.81-7.80 (m, 2H), 7.55-7.51 (m, 1H), 7.27-7.18 (m, 3H ), 7.12-6.99 (m, 6H), 2.28 (s, 3H).

실시예Example 28. 2-(2- 28. 2- (2- ChlorophenylChlorophenyl )-3-) -3- phenylquinazolinphenylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00072
Figure 112013099632120-pat00072

벤즈알데히드 대신에 2-클로로벤즈알데히드를 사용한 것을 제외하고는 실시예 22의 방법으로 목적하는 화합물을 얻었다. 반응시간 48시간.The target compound was obtained by the method of Example 22 except that 2-chlorobenzaldehyde was used instead of benzaldehyde. Reaction time 48 hours.

A white solid. Yield: 0.226 g (68 %). 1H NMR (400 MHz, CDCl3, ppm) δ 8.37 (d, J = 7.83 Hz, 1H), 7.83-7.82 (m, 2H), 7.58-7.54 (m, 1H), 7.40-7.26 (m, 4H), 7.22-7.08 (m, 5H).
A white solid. Yield: 0.226 g (68%). 1 H NMR (400 MHz, CDCl 3 , ppm)? 8.37 (d, J = 7.83 Hz, 1H), 7.83-7.82 (m, 2H), 7.58-7.54 (m, 1H), 7.40-7.26 ), 7.22-7.08 (m, 5H).

실시예Example 29. 2-( 29. 2- ( FuranFuran -2--2- ylyl )-3-) -3- phenylquinazolinphenylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00073
Figure 112013099632120-pat00073

벤즈알데히드 대신에 퓨란-2-카브알데히드를 사용한 것을 제외하고는 실시예 21의 방법으로 목적하는 화합물을 얻었다. 반응시간 48시간.2-carbaldehyde was used in place of benzaldehyde, the objective compound was obtained. Reaction time 48 hours.

A light yellow solid. Yield: 0.187 g (65%).
A light yellow solid. Yield: 0.187 g (65%).

실시예Example 30. 3- 30. 3- PhenylPhenyl -2-(-2-( thiophenthiophen -2--2- ylyl )) quinazolinquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00074
Figure 112013099632120-pat00074

벤즈알데히드 대신에 티오펜-2-카브알데히드를 사용한 것을 제외하고는 실시예 22의 방법으로 목적하는 화합물을 얻었다. 반응시간 48시간.The desired compound was obtained by the method of Example 22 except that thiophene-2-carbaldehyde was used instead of benzaldehyde. Reaction time 48 hours.

A light yellow solid. Yield: 0.222 g (73 %). 1H NMR (400 MHz, CDCl3, ppm) δ 8.26 (d, J = 7.83 Hz, 1H), 7.75-7.74 (m, 2H), 7.51-7.44 (m, 4H), 7.33-7.32 (m, 3H), 6.75-6.74 (m, 1H), 6.33-6.32 (m, 1H).
A light yellow solid. Yield: 0.222 g (73%). 1 H NMR (400 MHz, CDCl 3 , ppm)? 8.26 (d, J = 7.83 Hz, 1 H), 7.75-7.74 (m, 2H), 7.51-7.44 (m, 4H), 7.33-7.32 ), 6.75-6.74 (m, 1 H), 6.33 - 6.32 (m, 1 H).

실시예Example 31. 3- 31. 3- phenylquinazolinphenylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00075
Figure 112013099632120-pat00075

벤즈알데히드 대신에 포름알데히드를 사용한 것을 제외하고는 실시예 22의 방법으로 목적하는 화합물을 얻었다. The objective compound was obtained by the method of Example 22 except that formaldehyde was used instead of benzaldehyde.

A white solid. Yield: 0.084 g (38%). 1H NMR (400 MHz, CDCl3, ppm) δ 8.38 (d, J = 8.22 Hz, 1H), 8.15 (s, 1H), 7.83-7.77 (m, 2H), 7.58-7.43 (m, 6H).
A white solid. Yield: 0.084 g (38%). 1 H NMR (400 MHz, CDCl 3, ppm) δ 8.38 (d, J = 8.22 Hz, 1H), 8.15 (s, 1H), 7.83-7.77 (m, 2H), 7.58-7.43 (m, 6H).

실시예Example 32. 2- 32. 2- HexylHexyl -3--3- phenylquinazolinphenylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00076
Figure 112013099632120-pat00076

벤즈알데히드 대신에 헵타날을 사용한 것을 제외하고는 실시예 22의 방법으로 목적하는 화합물을 얻었다. 반응시간 48시간.The objective compound was obtained by the method of Example 22 except that heptanal was used instead of benzaldehyde. Reaction time 48 hours.

A white solid. Yield: 0.129 g (42 %). 1H NMR (400 MHz, CDCl3, ppm) δ 8.27 (d, J = 7.83 Hz, 1H), 7.79-7.70 (m, 2H), 7.58-7.44 (m, 4H), 7.27-7.25 (m, 2H), 2.42 (t, J = 7.83 Hz, 2H), 1.67 (m, 3H), 1.23-1.18 (m, 5H), 0.83 (dd, J = 7.04, 6.65 Hz, 3H).
A white solid. Yield: 0.129 g (42%). 1 H NMR (400 MHz, CDCl 3 , ppm)? 8.27 (d, J = 7.83 Hz, 1H), 7.79-7.70 (m, 2H), 7.58-7.44 (m, 4H), 7.27-7.25 ), 2.42 (t, J = 7.83 Hz, 2H), 1.67 (m, 3H), 1.23-1.18 (m, 5H), 0.83 (dd, J = 7.04,6.65 Hz, 3H).

실시예Example 33. 3- 33. 3- benzylbenzyl -2--2- phenylquinazolinphenylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00077
Figure 112013099632120-pat00077

N-페닐-안트라닐아미드 대신에 N-벤질-안트라닐아미드를 사용한 것을 제외하고는 실시예 22의 방법으로 목적하는 화합물을 얻었다. 반응시간 48시간.The objective compound was obtained by the method of Example 22 except that N-benzyl-anthranylamide was used instead of N-phenyl-anthranylamide. Reaction time 48 hours.

A white solid. Yield: 0.269 g (86%). 1H NMR (400 MHz, CDCl3, ppm) δ8.38 (d, J = 8.22 Hz, 1H), 7.80-7.75 (m, 2H), 7.54-7.52 (m, 1H), 7.48-7.44 (m, 1H), 7.41-7.33 (m, 4H), 7.21-7.19 (m, 3H), 6.94-6.92 (m, 2H), 5.27 (s, 2H).
A white solid. Yield: 0.269 g (86%). 1 H NMR (400 MHz, CDCl 3, ppm) δ8.38 (d, J = 8.22 Hz, 1H), 7.80-7.75 (m, 2H), 7.54-7.52 (m, 1H), 7.48-7.44 (m, 1H), 7.41-7.33 (m, 4H), 7.21-7.19 (m, 3H), 6.94-6.92 (m, 2H), 5.27 (s, 2H).

실시예Example 34. 3- 34. 3- methylmethyl -2--2- phenylquinazolinphenylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00078
Figure 112013099632120-pat00078

N-페닐-안트라닐아미드 대신에 N-메틸-안트라닐아미드를 사용한 것을 제외하고는 실시예 22의 방법으로 목적하는 화합물을 얻었다. 반응시간 48시간.The objective compound was obtained by the method of Example 22 except that N-methyl-anthranylamide was used instead of N-phenyl-anthranylamide. Reaction time 48 hours.

A white solid. Yield: 0.188 g (80%). 1H NMR (400 MHz, DMSO, ppm) δ 8.19 (d, J = 8.22 Hz, 1H), 7.84 (dd, J = 7.83, 7.43 Hz, 1H), 7.69-7.67 (m, 3H), 7.59-7.55 (m, 4H), 3.36 (s, 3H).
A white solid. Yield: 0.188 g (80%). 1 H NMR (400 MHz, DMSO , ppm) δ 8.19 (d, J = 8.22 Hz, 1H), 7.84 (dd, J = 7.83, 7.43 Hz, 1H), 7.69-7.67 (m, 3H), 7.59-7.55 (m, 4 H), 3.36 (s, 3 H).

실시예Example 35. 3- 35. 3- methylquinazolinmethylquinazoline -4(3H)--4 (3H) - oneone 의 제조Manufacturing

Figure 112013099632120-pat00079
Figure 112013099632120-pat00079

N-페닐-안트라닐아미드 대신에 N-메틸-안트라닐아미드를 사용한 것을 제외하고는 실시예 22의 방법으로 목적하는 화합물을 얻었다. 반응시간 48시간.The objective compound was obtained by the method of Example 22 except that N-methyl-anthranylamide was used instead of N-phenyl-anthranylamide. Reaction time 48 hours.

A white solid. Yield: 42%.
A white solid. Yield: 42%.

실시예Example 36. 2-(4- 36. 2- (4- hydroxybutylhydroxybutyl )) quinazolinquinazoline -4(3H)--4 (3H) - oneone 의 제조 Manufacturing

Figure 112013099632120-pat00080
Figure 112013099632120-pat00080

반응용기에 안트라닐아미드 1.0 mmol, 3,4-디히드로-2H-피란 1.2 mmol 및 p-톨루엔설포닉산(TsOH) 10 mol%를 넣고, 디메틸설폭사이드 5 mL에 용해시킨 후 오픈플라스크 시스템으로 100 ℃에서 교반시켰으며, 중간에 박막크로마토그래피법으로 반응 진행 여부를 확인하였다. 24시간 후, 반응이 종료되면 물과 디에틸에테르로 추출한 뒤 유기층을 모아 건조제(마그네슘설페이트)로 물을 제거한 후 농축시켰다. 상기 농축물을 실리카겔 컬럼크로마토 그래피법으로 분리하여 목적하는 화합물을 얻었다. 1.0 mmol of anthranilamide, 1.2 mmol of 3,4-dihydro-2H-pyran and 10 mol% of p-toluenesulfonic acid (TsOH) were dissolved in 5 mL of dimethylsulfoxide, And the reaction progress was confirmed by thin film chromatography method in the middle. After 24 hours, the reaction mixture was extracted with water and diethyl ether. The organic layer was collected, and water was removed with a desiccant (magnesium sulfate), followed by concentration. The concentrate was separated by silica gel column chromatography to obtain the desired compound.

A white solid. Yield: 0.112 g (51 %). 1H NMR (400 MHz, DMSO, ppm) δ 12.18 (s, br, 1H), 8.08 (d, J = 7.83 Hz, 1H), 7.77 (dd, J = 8.22, 6.65 Hz, 1H), 7.59 (d, J = 7.83 Hz, 1H), 7.46 (t, J = 7.43 Hz, 1H), 4.42 (s, br, 1H), 3.42 (dd, J = 6.65, 6.26 Hz, 2H), 2.60 (dd, J = 7.83, 7.43 Hz, 2H), 1.75 (m, 2H), 1.47 (m, 2H).
A white solid. Yield: 0.112 g (51%). 1 H NMR (400 MHz, DMSO , ppm) δ 12.18 (s, br, 1H), 8.08 (d, J = 7.83 Hz, 1H), 7.77 (dd, J = 8.22, 6.65 Hz, 1H), 7.59 (d , J = 7.83 Hz, 1H) , 7.46 (t, J = 7.43 Hz, 1H), 4.42 (s, br, 1H), 3.42 (dd, J = 6.65, 6.26 Hz, 2H), 2.60 (dd, J = 7.83, 7.43 Hz, 2H), 1.75 (m, 2H), 1.47 (m, 2H).

실시예Example 37. N,2- 37. N, 2- diphenylquinazolindiphenylquinazoline -4--4- amineamine 의 제조 (( oneone -- potpot reactionreaction 1) One)

Figure 112013099632120-pat00081
Figure 112013099632120-pat00081

반응용기에 안트라닐아미드 1.0 mmol, 벤즈알데히드 1.2 mmol 및 디메틸설폭사이드 3.0 mmol을 넣고 디메틸포름아미드 5 mL에 용해시킨 후 오픈플라스크 시스템으로 100 ℃에서 교반시켰으며, 중간에 박막크로마토그래피법으로 반응 진행 여부를 확인하였다. 48시간 후 안트라닐아미드가 모두 소진되어 반응 종료시키고, 실온으로 냉각시킨 뒤 포스포릴 클로라이드(POCl3) 2.0 mmol을 첨가하여 50 ℃에서 추가 교반하였다. 퀴나졸리논이 모두 소진된 후, 아닐린 1.1 mmol을 첨가하여 50 ℃에서 추가 교반하였으며, 중간에 박막크로마토그래피법으로 반응 진행 여부를 확인하였다. 반응 종료후 물과 디에틸에테르로 추출한 뒤, 유기층을 모아 건조제(마그네슘설페이트)로 물을 제거한 후 농축시켰다. 상기 농축물을 헥산:에틸아세테이트=7:1인 용매를 사용하여 실리카겔 컬럼크로마토 그래피법으로 분리하여 목적하는 화합물을 얻었다. 1.0 mmol of anthranylamide, 1.2 mmol of benzaldehyde and 3.0 mmol of dimethylsulfoxide were placed in a reaction vessel and dissolved in 5 mL of dimethylformamide, followed by stirring at 100 ° C in an open flask system. Respectively. After 48 hours, the anthranilamide was exhausted to complete the reaction. After cooling to room temperature, 2.0 mmol of phosphoryl chloride (POCl 3 ) was added and further stirred at 50 ° C. After the quinazolinone was exhausted, 1.1 mmol of aniline was added and the mixture was further stirred at 50 DEG C, and the reaction progress was confirmed by thin film chromatography in the middle. After completion of the reaction, the reaction mixture was extracted with water and diethyl ether, and the organic layer was collected, and water was removed with a desiccant (magnesium sulfate), followed by concentration. The concentrate was separated by silica gel column chromatography using a solvent of hexane: ethyl acetate = 7: 1 to obtain the desired compound.

A white solid. Yield: 0.111 g (37 %). 1H NMR (400 MHz, DMSO, ppm) δ 9.90 (s, 1H), 8.61-8.59 (d, J = 7.83 Hz, 1H), 8.50-8.46 (m, 2H), 8.01-7.99 (d, J = 7.83 Hz, 2H), 7.89-7.76 (m, 2H), 7.63-7.47 (m, 6H), 7.19 (t, J = 7.04 Hz, 1H).
A white solid. Yield: 0.111 g (37%). 1 H NMR (400 MHz, DMSO , ppm) δ 9.90 (s, 1H), 8.61-8.59 (d, J = 7.83 Hz, 1H), 8.50-8.46 (m, 2H), 8.01-7.99 (d, J = 7.83 Hz, 2H), 7.89-7.76 (m, 2H), 7.63-7.47 (m, 6H), 7.19 (t, J = 7.04 Hz, 1H).

실시예Example 38. 8,9- 38. 8,9- dihydrodihydro -6H--6H- pyridopyrido [2,1-b]quinazolin-11(7H)-[2,1-b] quinazolin-11 (7H) - oneone 의 제조 (( oneone -- potpot reactionreaction 2) 2)

Figure 112013099632120-pat00082
Figure 112013099632120-pat00082

반응용기에 안트라닐아미드 1.0 mmol, 3,4-디히드로-2H-피란 1.2 mmol 및 p-톨루엔설포닉산(TsOH) 10 mol%를 넣고, 디메틸설폭사이드 5 mL에 용해시킨 후 오픈플라스크 시스템으로 100 ℃에서 교반시켰으며, 중간에 박막크로마토그래피법으로 반응 진행 여부를 확인하였다. 반응이 종료되면 실온으로 식힌 뒤, 디잇프로필 아조디카르복실레이트 1.1 mmol 및 트리페닐포스핀 1.3 mmol을 첨가하고 추가 ryks 시켰다. 반응이 종료된 후, 반응 혼합물을 물과 디에틸에테르로 추출한 뒤 유기층을 모아 건조제(마그네슘설페이트)로 물을 제거한 후 농축시켰다. 상기 농축물을 헥산:에틸아세테이트=5:1인 용매를 사용하여 실리카겔 컬럼크로마토 그래피법으로 분리하여 목적하는 화합물을 얻었다. 1.0 mmol of anthranilamide, 1.2 mmol of 3,4-dihydro-2H-pyran and 10 mol% of p-toluenesulfonic acid (TsOH) were dissolved in 5 mL of dimethylsulfoxide, And the reaction progress was confirmed by thin film chromatography method in the middle. After the reaction was completed, the mixture was cooled to room temperature, and then 1.1 mmol of di-propyl azodicarboxylate and 1.3 mmol of triphenylphosphine were added and ryks were further added. After the reaction was completed, the reaction mixture was extracted with water and diethyl ether, and then the organic layer was collected, and water was removed with a desiccant (magnesium sulfate), followed by concentration. The concentrate was separated by silica gel column chromatography using a solvent of hexane: ethyl acetate = 5: 1 to obtain the desired compound.

A white solid. Yield: 0.113 g (56 %). 1H NMR (400 MHz, DMSO, ppm) δ 8.09 (d, J = 7.83 Hz, 1H), 7.77 (t, J = 7.43 Hz, 1H), 7.56 (d, J = 7.83 Hz, 1H), 7.45 (dd, J = 7.43, 7.04 Hz, 1H), 3.94 (t, J = 5.87 Hz, 2H), 2.90 (t, J = 6.26 Hz, 2H), 1.91-1.82 (m, 4H).
A white solid. Yield: 0.113 g (56%). 1 H NMR (400 MHz, DMSO , ppm) δ 8.09 (d, J = 7.83 Hz, 1H), 7.77 (t, J = 7.43 Hz, 1H), 7.56 (d, J = 7.83 Hz, 1H), 7.45 ( (d, J = 7.43, 7.04 Hz, 1H), 3.94 (t, J = 5.87 Hz, 2H), 2.90 (t, J = 6.26 Hz, 2H), 1.91-1.82 (m, 4H).

시험예Test Example 1. One.

반응 환경에 따른 합성 수율을 확인하기 위하여, 안트라닐아미드와 벤즈알데히드를 다양한 유기용매 및 온도에서 반응을 수행하였으며, 이를 하기 [반응식 2] 및 표 1,2 에 나타내었다. In order to confirm the synthesis yield according to the reaction environment, anthranilamide and benzaldehyde were reacted at various organic solvents and temperatures, as shown in Reaction Scheme 2 and Tables 1 and 2 below.

[반응식 2][Reaction Scheme 2]

Figure 112013099632120-pat00083

Figure 112013099632120-pat00083

시험예Test Example 1.1. 용매변화 1.1. Solvent change

반응온도는 100 ℃로 고정하고 상기 [반응식 2]에 따라 튀나졸리논을 합성하였다. 하기 표 1에 나타낸 바와 같이, 디메틸설폭사이드를 용매로 사용하는 경우에는, 12시간 안에 반응이 모두 진행되었다(반응조건 1.1). 반면 디메틸설폭사이드에 포어 크기가 4Å인 molecular seives(분자체)를 첨가한 경우 퀴나졸리논이 반응이 진행되지 않았으며, 일부가 이민 중간체를 형성하였다. 상기와 같은 결과를 통해 수분이 반응에 영향을 미치는 것을 확인하였다. 한편, 용매를 디메틸포름아미드로 사용하는 경우, 반응의 진행속도도 느렸으며, 이민 중간체의 비율도 높았다. 용매를 물로 사용하는 경우에는, 대부분이 이민 중간체를 형성하였으며, 퀴나졸리논은 생성되지 않았다. 상기 결과를 통해, 본 발명에 따른 퀴나졸리논 제조방법은 수분을 제거하지 않은(또는 수분을 포함하는) 디메틸설폭사이드 용매하에서 이루어지는 것임을 확인하였다. The reaction temperature was fixed at 100 占 폚 and thunazolinone was synthesized according to the above Reaction Scheme 2. As shown in the following Table 1, when dimethylsulfoxide was used as a solvent, all the reactions proceeded within 12 hours (reaction condition 1.1). On the other hand, when molecular sieves (molecular sieves) having a pore size of 4 Å were added to dimethyl sulfoxide, the quinazolinone did not react and partly formed an imine intermediate. As a result, it was confirmed that moisture affects the reaction. On the other hand, when the solvent was used as dimethylformamide, the rate of the reaction was slow and the ratio of the imine intermediate was high. When the solvent was used as water, most of it formed an imine intermediate, and no quinazolinone was produced. From the above results, it was confirmed that the process for preparing quinazolinone according to the present invention is carried out in a dimethylsulfoxide solvent not containing water (or containing water).

구분division 용매menstruum 반응시간(h)Reaction time (h) 수율(%)
1a:3a:4a
yield(%)
1a: 3a: 4a
기타Other
반응조건 1.1Reaction conditions 1.1 DMSODMSO 1212 68:32:068: 32: 0 4ÅMS 첨가4 ÅMS addition 반응조건 1.2Reaction conditions 1.2 DMSODMSO 1212 0:0:1000: 0: 100 -- 반응조건 1.3Reaction conditions 1.3 DMFDMF 1212 18:38:4418:38:44 -- 반응조건 1.4Reaction conditions 1.4 1,4-dioxane1,4-dioxane 1212 21:55:2421:55:24 -- 반응조건 1.5Reaction conditions 1.5 H2OH 2 O 1212 0:100:00: 100: 0 -- 반응조건 1.6Reaction conditions 1.6 toluenetoluene 1212 36:64:036: 64: 0 --

상기 표 1에서, In Table 1,

DMSO는 디메틸설폭사이드이며, DMSO is dimethyl sulfoxide,

DMF는 디메틸포름아미드이고, DMF is dimethylformamide,

4ÅMS는 포어 크기가 4Å인 molecular seives이다.
4 ÅMS is molecular seives with a pore size of 4 Å.

시험예Test Example 1.2. 온도변화 1.2. Temperature change

반응용매는 디메틸설폭사이드로 고정하고 상기 [반응식 2]에 따라 퀴나졸리논을 합성하였다. 상기 표 2에 나타낸 바와 같이, 열을 가하지 않은 실험실의 온도(반응조건 2.1)에서는 24시간의 반응에서도 반응이 진행되지 않았으며, 반응온도가 60 ℃ 및 80 ℃인 조건에서는 퀴나졸리논이 미량 검출되었다. 반면, 100 ℃에서는 12시간 만에 출발물질이 모두 소진되었으며, 생성된 화합물은 퀴나졸리논으로 확인되었고, 120 ℃로 반응시킨 경우 3.5시간 만에 반응이 완료되었다. 상기 결과를 통해 본 발명에 따른 퀴나졸리논 제조방법은 100 ℃이상의 온도에서 수행하는 것이 바람직함을 확인하였다.
The reaction solvent was fixed with dimethylsulfoxide and quinazolinone was synthesized according to the above-mentioned Reaction Scheme 2. As shown in Table 2, the reaction did not proceed even in the 24-hour reaction at the temperature of the non-heated laboratory (reaction condition 2.1). When the reaction temperature was 60 ° C and 80 ° C, the quinazolinone . On the other hand, the starting material was completely consumed in 12 hours at 100 ° C, and the resulting compound was identified as quinazolinone. When the reaction was carried out at 120 ° C, the reaction was completed within 3.5 hours. From the above results, it was confirmed that the process for preparing quinazolinone according to the present invention is preferably carried out at a temperature of 100 ° C or higher.

구분division 온도(℃)Temperature (℃) 반응시간(h)Reaction time (h) 수율(%) yield(%) 반응조건 2.1Reaction conditions 2.1 room Temp.room Temp. 2424 No reactionNo reaction 반응조건 2.2Reaction conditions 2.2 6060 2424 미량검출Trace detection 반응조건 2.3Reaction conditions 2.3 8080 2424 미량검출Trace detection 반응조건 2.4Reaction conditions 2.4 100100 1212 >99> 99 반응조건 2.5Reaction conditions 2.5 120120 3.53.5 >99> 99

시험예Test Example 2.  2.

본 발명에 따른 퀴나졸리논 제조방법이 산소원에 의한 산화반응인 것을 증명하기 위하여 산소가 배제된 아르곤 기류하에서 반응을 실시하였다. 그러나, 아르곤 분위기하에서는 반응이 진행되지 않았다.
In order to prove that the process of preparing the quinazolinone according to the present invention is an oxidation reaction by an oxygen source, the reaction was carried out under an argon atmosphere in which oxygen was excluded. However, the reaction did not proceed under an argon atmosphere.

시험예Test Example 3. 3.

본 발명에 따른 퀴나졸리논 제조방법에 있어서 친핵체에 따른 영향을 확인하기 위하여 이민중간체에 다양한 친핵체를 첨가하여 반응을 실시하였으며 이를 하기 [반응식 3] 및 표 3에 나타내었다. In order to confirm the effect of the nucleophiles on the preparation of the quinazolinones according to the present invention, various nucleophiles were added to the imine intermediate to carry out the reaction, and these are shown in the following Scheme 3 and Table 3.

[반응식 3][Reaction Scheme 3]

Figure 112013099632120-pat00084
Figure 112013099632120-pat00084

상기 [반응식 3]에서In the above Reaction Scheme 3,

Nu는 친핵체(Nucleophile)이다.
Nu is a nucleophile.

구분division 친핵체Nucleophile 반응시간(h)Reaction time (h) 수율(%) yield(%) 기타Other 반응조건 3.1Reaction conditions 3.1 NaCNNaCN 2424 5757 -- 반응조건 3.2Reaction conditions 3.2 KIKI 2424 4545 -- 반응조건 3.3Reaction conditions 3.3 NaINaI 2424 6666 -- 반응조건 3.4Reaction conditions 3.4 NaOPhNaOPh 2424 5656 -- 반응조건 3.5Reaction conditions 3.5 NaOAcNaOAc 2424 5858 -- 반응조건 3.6Reaction conditions 3.6 -- 1818 9494 -- 반응조건 3.7Reaction conditions 3.7 -- 2424 <5<5 Ar 기류하Ar airflow

상기 표 3에 나타낸 바와 같이, 아무것도 넣지 않은 반응조건 3.6에서 가장 우수한 수율로 퀴나졸리논이 생성되었으며, 친핵체의 존재하에서는 오히려 수율이 떨어지는 것을 확인할 수 있었다. As shown in Table 3, it was confirmed that the quinazolinone was produced in the most excellent yield under the reaction condition 3.6 in which nothing was added, and the yield was lowered in the presence of the nucleophile.

Claims (7)

하기 [화학식 2]로 표시되는 화합물;과 하기 [화학식 3] 또는 3,4-디히드로피란;을 디메틸설폭사이드 용매하에서 80-200 ℃로 반응시킴으로써 하기 [화학식 1]로 표시되는 화합물을 제조하는 것을 특징으로 하는 퀴나졸리논 유도체의 제조방법:
[화학식 1]
Figure 112015072529320-pat00085

[화학식 2]
Figure 112015072529320-pat00086

[화학식 3] [3,4-디히드로피란]
Figure 112015072529320-pat00100
Figure 112015072529320-pat00101

상기 [화학식 1] 내지 [화학식 3]에서,
R1, R2 및 R3는 서로 동일하거나 상이하고, 각각 독립적으로 수소, 할로겐, C1-C10의 직쇄상, 분쇄상 또는 고리상의 탄소사슬을 포함하는 알킬기, 페닐기, 페닐프로페닐기, C7-C14의 알킬페닐기, C7-C14의 알콕시페닐기, 니트로페닐기, 메톡시카보닐페닐, 에톡시카보닐페닐, 아미노페닐기, 시아노페닐, 할로페닐기, 디할로페닐, 트리할로페닐, 퍼할로페닐, 나프틸기, 안트라세닐기 및 C4-C12의 헤테로아릴기 중에서 선택된다.
A compound represented by the following formula (1) is prepared by reacting a compound represented by the following formula (2) and the following formula (3) or 3,4-dihydropyrane in a dimethylsulfoxide solvent at 80-200 캜 &Lt; RTI ID = 0.0 &gt; 1, &lt; / RTI &gt;
[Chemical Formula 1]
Figure 112015072529320-pat00085

(2)
Figure 112015072529320-pat00086

[Chemical Formula 3] [3,4-dihydropyran]
Figure 112015072529320-pat00100
Figure 112015072529320-pat00101

In the above Chemical Formulas 1 to 3,
R 1 , R 2 and R 3 are the same or different and are each independently selected from the group consisting of hydrogen, halogen, an alkyl group containing a carbon chain in the form of a straight, branched or cyclic chain selected from the group consisting of C 1 -C 10, phenyl, phenylpropenyl, C 7 -C 14 C7-C14 alkoxyphenyl, nitrophenyl, methoxycarbonylphenyl, ethoxycarbonylphenyl, aminophenyl, cyanophenyl, halophenyl, dihalophenyl, trihalophenyl, perhalophenyl, naphthyl, Anthracenyl group, and a C4-C12 heteroaryl group.
제1항에 있어서,
상기 반응은 산소 및 공기 중에서 선택되는 1종 이상의 산소원을 산화제로 사용하여 수행되는 것을 특징으로 하는 퀴나졸리논 유도체의 제조방법.
The method according to claim 1,
Wherein the reaction is carried out using at least one oxygen source selected from oxygen and air as an oxidizing agent.
삭제delete 제1항에 있어서,
상기 반응은 1-60시간 동안 반응시킴으로써 수행되는 것을 특징으로 하는 퀴나졸리논 유도체의 제조방법.
The method according to claim 1,
Wherein the reaction is carried out by reacting for 1 to 60 hours.
제1항에 있어서,
상기 알킬기는 메틸, 에틸, 노말프로필, 이소프로필, 노말부틸, 이소부틸, tert-부틸, 노말헥실, 이소헥실, 시클로헥실, 노말헵틸, 이소헵틸 및 시클로헵틸로 이루어진 군 중에서 선택되고,
상기 알킬페닐기는 메틸페닐, 에틸페닐, 프로필페닐, 디메틸페닐, 디에틸페닐 및 메틸에틸페닐로 이루어진 군 중에서 선택되며,
상기 알콕시페닐기는 메톡시페닐 및 에톡시페닐로 이루어진 군중에서 선택되고,
상기 헤테로아릴기는 퓨라닐기, 메틸퓨라닐, 에틸퓨라닐, 디메틸퓨라닐, 디에틸퓨라닐, 티오펜일(thiophenyl)기, 메틸티오펜일, 에틸티오펜일, 디메틸티오펜일, 디에틸티오펜일 및 피리디닐기로 이루어진 군 중에서 선택되는 1종 이상인 것을 특징으로 하는 퀴나졸리논 유도체의 제조방법.
The method according to claim 1,
Wherein said alkyl group is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-hexyl, isohexyl, cyclohexyl, normal heptyl, isoheptyl and cycloheptyl,
Wherein the alkylphenyl group is selected from the group consisting of methylphenyl, ethylphenyl, propylphenyl, dimethylphenyl, diethylphenyl and methylethylphenyl,
Wherein said alkoxyphenyl group is selected from the group consisting of methoxyphenyl and ethoxyphenyl,
Wherein said heteroaryl group is selected from the group consisting of furanyl, methylfuranyl, ethylfuranyl, dimethylfuranyl, diethylfuranyl, thiophenyl, methylthiophenyl, ethylthiophenyl, dimethylthiophenyl, A thiophene group, a thiophene group, a thiophene group, a thienylthio group, a thienylthio group, a thienylthio group, a thienylthio group, a thienylthio group,
제1항에 있어서,
상기 반응은 물을 부산물로 생산하는 것을 특징으로 하는 퀴나졸리논 유도체의 제조방법.
The method according to claim 1,
Wherein said reaction is to produce water as a by-product.
제1항에 있어서,
상기 반응은 물을 더 포함하는 것을 특징으로 하는 퀴나졸리논 유도체의 제조방법.
The method according to claim 1,
Wherein the reaction further comprises water. &Lt; RTI ID = 0.0 &gt; 11. &lt; / RTI &gt;
KR1020130132156A 2013-11-01 2013-11-01 Development of a New Synthetic Method for Quinazolinones via Aerobic Oxidation in dimethylsulfoxide KR101580821B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020130132156A KR101580821B1 (en) 2013-11-01 2013-11-01 Development of a New Synthetic Method for Quinazolinones via Aerobic Oxidation in dimethylsulfoxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020130132156A KR101580821B1 (en) 2013-11-01 2013-11-01 Development of a New Synthetic Method for Quinazolinones via Aerobic Oxidation in dimethylsulfoxide

Publications (2)

Publication Number Publication Date
KR20150050914A KR20150050914A (en) 2015-05-11
KR101580821B1 true KR101580821B1 (en) 2015-12-30

Family

ID=53388542

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020130132156A KR101580821B1 (en) 2013-11-01 2013-11-01 Development of a New Synthetic Method for Quinazolinones via Aerobic Oxidation in dimethylsulfoxide

Country Status (1)

Country Link
KR (1) KR101580821B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115403520B (en) * 2022-08-30 2023-12-19 浙江理工大学 Preparation method of quinoline-2 (1H) -ketone derivative

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Synthesis, 2013, Vol.45, pages 2998-3006

Also Published As

Publication number Publication date
KR20150050914A (en) 2015-05-11

Similar Documents

Publication Publication Date Title
JP5265562B2 (en) Process for the preparation of imatinib and its intermediates
Zhao et al. Oxidative sulfonamidomethylation of imidazopyridines utilizing methanol as the main C1 source
JP6732744B2 (en) Method for producing biphenylamines from azobenzols by ruthenium catalysis
KR20190013553A (en) Improved process for preparing aminopyrimidine derivatives
Le Phuong et al. Environmentally benign and diastereoselective synthesis of 2, 4, 5-trisubstituted-2-imidazolines
KR101728443B1 (en) Method for Producing Benzyl Ester 2-aminonicotinicotinate Derivative
JP6705458B2 (en) Method for producing triazole compound
KR101580821B1 (en) Development of a New Synthetic Method for Quinazolinones via Aerobic Oxidation in dimethylsulfoxide
Zhang et al. Copper (I)‐Catalyzed Intramolecular N‐N Coupling of Cyclopropyl O‐Acyl Ketoximes: Synthesis of Spiro‐fused Pyrazolin‐5‐ones
Kumazawa et al. Metal-Free Synthesis of N-Containing Heterocycles from o-Substituted Aniline Derivatives via 2, 4, 6-Trihydroxybenzoic Acid-Catalyzed Oxidative Dehydrogenation of Benzylamines under Oxygen Atmosphere
JP2020528437A (en) A novel intermediate useful for the synthesis of aminopyrimidine derivatives, the process for preparing it, and the process for preparing aminopyrimidine derivatives using it.
KR20160027537A (en) Process for preparing silodosin
KR102246226B1 (en) Manufacturing method of losartan metabolite exp-3174
KR101623810B1 (en) Synthesis of furan, thiophene, and pyrroles from acetoacetic esters
KR101638331B1 (en) Synthetic Method of Benzimidazole via Aerobic Oxidation
KR101653532B1 (en) Synthesis of Benzimidazoles bearing borionic acid functionality via metal-free aerobic oxidation
KR102212650B1 (en) Method for synthesizing thioaurones
KR101554539B1 (en) Development of Method for Amide Bond Formation via Metal-Free Aerobic Oxidative Amination of Aldehydes
KR102037758B1 (en) 3-ALKYLATED IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AND ITS PREPARATION METHOD
DUMITRAŞCU et al. New substituted indolizines by 1, 3-dipolar cycloaddition reactions. Part 2. 7-Cyanoindolizines
Zhang et al. Selective synthesis of polyfunctionalized hydroisoquinoline derivatives via a three-component domino reaction
KR101815001B1 (en) 4-Substituted-5-membered-ring-sulfamidate-5-phosphonate compounds and Method for the stereoselective preparation thereof
CN113214224A (en) Preparation method of polysubstituted 3-methylene isoindolinone derivative
CN106278968B (en) A kind of method for synthesizing sulfo-amino acid derivative
KR20210049293A (en) Method for synthesizing (z)-aurone and derivative compounds thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20181025

Year of fee payment: 4